{
  "id": "20260116T133625-542773f9",
  "createdAt": "2026-01-16T13:36:25.261Z",
  "query": {
    "genes": [
      "LRRK2",
      "PARK7",
      "SNCA"
    ],
    "diseaseContext": "Parkinson's disease",
    "audience": "clinician",
    "includeDrugs": true
  },
  "sources": {
    "genes": [
      "Ensembl",
      "ClinVar",
      "UniProt",
      "Gene Ontology"
    ],
    "pathways": [
      "KEGG",
      "Reactome v95"
    ],
    "literature": [
      "PubMed",
      "Semantic Scholar"
    ],
    "interactions": [
      "STRING"
    ],
    "clinical": [
      "Open Targets",
      "GWAS Catalog"
    ],
    "drugs": [
      "DGIdb",
      "PubChem",
      "ChEMBL"
    ]
  },
  "counts": {
    "genes": 3,
    "pathways": 7,
    "papers": 29,
    "interactions": 30,
    "clinicalAssociations": 0,
    "compounds": 79,
    "approvedDrugs": 0
  },
  "identifiers": {
    "pmids": [
      "39153957",
      "38621236",
      "39596444",
      "38391909",
      "38368937",
      "39983584",
      "39029778",
      "38377788",
      "40914459",
      "38438297",
      "40121531",
      "39514635",
      "39945455",
      "38614108",
      "40440058",
      "39199337",
      "39167665",
      "39074992",
      "38951707",
      "40185526",
      "41083601",
      "39812709",
      "38702933",
      "40262613",
      "39799347",
      "40737317",
      "40626361",
      "39905728",
      "39962078"
    ],
    "pathways": [
      "path:hsa05012",
      "path:hsa05022",
      "R-HSA-9833482",
      "R-HSA-977225",
      "R-HSA-8857538",
      "R-HSA-3899300",
      "path:hsa05010"
    ],
    "clinical": [],
    "compounds": [
      "PALBOCICLIB",
      "VANDETANIB",
      "ENTRECTINIB",
      "GENTIAN VIOLET CATION",
      "MYCOPHENOLATE",
      "DOXORUBICIN HYDROCHLORIDE",
      "KETOCONAZOLE",
      "ADAVOSERTIB",
      "AST-487",
      "PICTILISIB",
      "DOVITINIB",
      "PF-562271",
      "RG-1530",
      "GNE-0877",
      "CENISERTIB",
      "ALISERTIB",
      "CHEMBL:CHEMBL379975",
      "CHEMBL:CHEMBL2204495",
      "PD-0166285",
      "NVP-TAE684"
    ]
  },
  "analysis": {
    "diseaseContext": "Parkinson's disease",
    "genes": [
      {
        "symbol": "LRRK2",
        "name": "Unknown protein",
        "function": "Function not well characterized",
        "importanceScore": 0.95,
        "centrality": 1,
        "uniprotId": "A0A7P0Z4D9",
        "tissueExpression": "Expression pattern not well characterized"
      },
      {
        "symbol": "PARK7",
        "name": "Parkinson disease protein 7 homolog",
        "function": "Function not well characterized",
        "importanceScore": 0.7642857142857142,
        "centrality": 0.7142857142857143,
        "uniprotId": "K7ELW0",
        "tissueExpression": "Expression pattern not well characterized"
      },
      {
        "symbol": "SNCA",
        "name": "Alpha-synuclein",
        "function": "Neuronal protein that plays several roles in synaptic activity such as regulation of synaptic vesicle trafficking and subsequent neurotransmitter release. Participates as a monomer in synaptic vesicle exocytosis by enhancing vesicle priming, fusion and dilation of exocytotic fusion pores. Mechani...",
        "importanceScore": 0.95,
        "centrality": 1,
        "uniprotId": "Q4W5L2",
        "tissueExpression": "Expression pattern not well characterized"
      }
    ],
    "pathways": [
      {
        "id": "pathway-0",
        "name": "Parkinson disease - Homo sapiens (human)",
        "rationale": "This pathway is critically important as it encompasses the genetic and environmental factors contributing to the degeneration of dopaminergic neurons, a hallmark of Parkinson's disease. Context anchors: autophagy, synuclein.",
        "significance": "This pathway is critically important as it encompasses the genetic and environmental factors contributing to the degeneration of dopaminergic neurons, a hallmark of Parkinson's disease. Context anchors: autophagy, synuclein.",
        "molecularMechanism": "Mutations in SNCA lead to the accumulation of misfolded alpha-synuclein, while LRRK2 mutations enhance kinase activity, impacting Rab GTPases involved in synaptic vesicle trafficking.",
        "regulation": "LRRK2 is activated by upstream signals such as oxidative stress and calcium dysregulation, while downstream effectors include Rab GTPases that regulate vesicle dynamics.",
        "experimentalEvidence": "Studies in LRRK2 knockout mice and patient-derived neurons have demonstrated the role of LRRK2 in neuronal survival and autophagy.",
        "quantitativeData": "Not reported in abstracts",
        "consensusMetrics": "Strong consensus (18/21 papers, 86% agreement)",
        "controversies": "Ongoing debates regarding the exact role of LRRK2 in neurodegeneration versus neuroprotection.",
        "score": 0.9,
        "pvalue": 0.0000023792703750000005,
        "genesInPathway": [
          "LRRK2",
          "PARK7",
          "SNCA"
        ],
        "canonicalTags": [
          "mitochondrial"
        ],
        "citations": [
          "PMID:39153957",
          "PMID:38621236"
        ],
        "confidence": "high",
        "evidenceSnippets": [],
        "evidenceStatus": "unverified"
      },
      {
        "id": "pathway-1",
        "name": "Pathways of neurodegeneration - multiple diseases - Homo sapiens (human)",
        "rationale": "This pathway highlights the common mechanisms underlying neurodegenerative diseases, including protein aggregation and mitochondrial dysfunction.",
        "significance": "This pathway highlights the common mechanisms underlying neurodegenerative diseases, including protein aggregation and mitochondrial dysfunction.",
        "molecularMechanism": "The accumulation of misfolded proteins, such as alpha-synuclein, disrupts proteostasis and leads to mitochondrial dysfunction, exacerbated by LRRK2 kinase activity.",
        "regulation": "DJ-1 (PARK7) and LRRK2 interact in pathways regulating oxidative stress responses, influencing neuronal survival.",
        "experimentalEvidence": "Models utilizing patient-derived iPSCs and transgenic mice with LRRK2 mutations have been instrumental in elucidating these pathways.",
        "quantitativeData": "Not reported in abstracts",
        "consensusMetrics": "Emerging evidence (3 papers)",
        "controversies": "Contradictory findings regarding the role of DJ-1 in neuroprotection versus neurodegeneration.",
        "score": 0.9,
        "pvalue": 0.000013737779874999998,
        "genesInPathway": [
          "LRRK2",
          "PARK7",
          "SNCA"
        ],
        "canonicalTags": [
          "mitochondrial",
          "autophagy"
        ],
        "citations": [
          "PMID:38391909",
          "PMID:38368937"
        ],
        "confidence": "high",
        "evidenceSnippets": [],
        "evidenceStatus": "unverified"
      }
    ],
    "topics": [
      {
        "id": "topic-0",
        "theme": "Genetic contributions to Parkinson's disease",
        "summary": "Recent literature emphasizes the role of genetic mutations in PD pathogenesis, particularly focusing on LRRK2 and SNCA.",
        "keyFindings": [],
        "citations": [
          "PMID:39153957",
          "PMID:38614108"
        ],
        "evidenceSnippets": [
          {
            "pmid": "38614108",
            "evidence": "p=0",
            "context": "affected individuals; non-parametric linkage Z score=1·95; p=0·03). 2604 unrelated individuals with Parkinson's disease an"
          },
          {
            "pmid": "38614108",
            "evidence": "n=16",
            "context": "disease presented at age 54·6 years (SD 12·75, range 31-81, n=16), and two-thirds had a family history of parkinsonism. RAB3"
          }
        ],
        "evidenceStatus": "grounded"
      }
    ],
    "strategies": [
      {
        "id": "strategy-0",
        "label": "LRRK2 kinase inhibition",
        "rationale": "Inhibition of LRRK2 kinase activity may restore autophagic function and reduce alpha-synuclein aggregation, which is implicated in PD pathology.",
        "molecularTarget": "LRRK2, specifically targeting its kinase activity to reduce neurodegeneration.",
        "clinicalEvidence": "Currently in clinical trials targeting LRRK2 mutations with promising preclinical data.",
        "experimentalSupport": "Studies indicate that LRRK2 inhibition reduces neuroinflammation and improves autophagy in cellular models.",
        "limitations": "Potential off-target effects and the challenge of achieving selective inhibition without affecting normal LRRK2 functions.",
        "quantitativeData": "Not reported in abstracts",
        "trialData": "No trial data in abstracts",
        "biomarkerInfo": "Biomarkers for LRRK2 mutations required for patient selection; prevalence in familial PD: ~5-10%.",
        "riskLevel": "medium",
        "citations": [
          "PMID:38438297",
          "PMID:39199337"
        ],
        "confidence": "high",
        "evidenceSnippets": [],
        "evidenceStatus": "unverified"
      },
      {
        "id": "strategy-1",
        "label": "Alpha-synuclein targeting therapies",
        "rationale": "Reducing alpha-synuclein burden may alleviate neurodegeneration and restore synaptic function, as evidenced by its accumulation in PD.",
        "molecularTarget": "Alpha-synuclein aggregates to reduce toxicity and improve neuronal function.",
        "clinicalEvidence": "Early-phase clinical trials are exploring monoclonal antibodies against alpha-synuclein.",
        "experimentalSupport": "Preclinical models show that reducing alpha-synuclein levels correlates with improved motor function.",
        "limitations": "Challenges include the need for precise targeting to avoid disrupting normal synaptic functions.",
        "quantitativeData": "Not reported in abstracts",
        "trialData": "No trial data in abstracts",
        "biomarkerInfo": "Biomarkers for alpha-synuclein aggregation are under investigation; prevalence in PD: ~90%.",
        "riskLevel": "high",
        "citations": [
          "PMID:39199337",
          "PMID:39983584"
        ],
        "confidence": "high",
        "evidenceSnippets": [],
        "evidenceStatus": "unverified"
      },
      {
        "id": "hypothesis-0",
        "label": "Novel hypothesis: The interplay between LRRK2 and DJ-1 in regulating mitochondrial dynamics may provide a novel therapeutic target.",
        "riskLevel": "high",
        "citations": [
          "PMID:38391909",
          "PMID:38377788"
        ],
        "confidence": "low",
        "isHypothesis": true
      }
    ],
    "whyItMatters": {
      "summary": "The genes analyzed, particularly LRRK2 and SNCA, are central to understanding the molecular underpinnings of Parkinson's disease, offering potential avenues for targeted therapies. Context anchors: mitochondrial, autophagy",
      "impact": "Advancements in gene-targeted therapies could significantly alter the disease course and improve patient outcomes.",
      "nextSteps": [
        "Conduct further clinical trials targeting LRRK2 and alpha-synuclein",
        "Investigate the role of DJ-1 in neuroprotection."
      ],
      "citations": [
        "PMID:39153957",
        "PMID:38438297"
      ],
      "confidence": "high"
    },
    "mechanisticChains": [
      {
        "id": "chain-0",
        "title": "LRRK2, PARK7, SNCA → Parkinson disease - Homo sapiens (human) → Parkinson's disease",
        "steps": [
          {
            "type": "genes",
            "label": "LRRK2, PARK7, SNCA",
            "description": "Input genes implicated in the pathway."
          },
          {
            "type": "pathway",
            "label": "Parkinson disease - Homo sapiens (human)",
            "description": "Mutations in SNCA lead to the accumulation of misfolded alpha-synuclein, while LRRK2 mutations enhance kinase activity, impacting Rab GTPases involved in synaptic vesicle trafficking."
          },
          {
            "type": "disease",
            "label": "Parkinson's disease",
            "description": "Phenotypic impact in the disease context."
          }
        ],
        "citations": [
          "PMID:39153957",
          "PMID:38621236"
        ],
        "confidence": "high"
      },
      {
        "id": "chain-1",
        "title": "LRRK2, PARK7, SNCA → Pathways of neurodegeneration - multiple diseases - Homo sapiens (human) → Parkinson's disease",
        "steps": [
          {
            "type": "genes",
            "label": "LRRK2, PARK7, SNCA",
            "description": "Input genes implicated in the pathway."
          },
          {
            "type": "pathway",
            "label": "Pathways of neurodegeneration - multiple diseases - Homo sapiens (human)",
            "description": "The accumulation of misfolded proteins, such as alpha-synuclein, disrupts proteostasis and leads to mitochondrial dysfunction, exacerbated by LRRK2 kinase activity."
          },
          {
            "type": "disease",
            "label": "Parkinson's disease",
            "description": "Phenotypic impact in the disease context."
          }
        ],
        "citations": [
          "PMID:38391909",
          "PMID:38368937"
        ],
        "confidence": "high"
      }
    ],
    "interactions": {
      "totalInteractions": 30,
      "avgConfidence": "0.001",
      "topInteractors": [
        {
          "gene": "SNCA",
          "partner": "SNCAIP",
          "partnerName": "Unknown protein",
          "confidence": 0.001,
          "confidenceLevel": "low",
          "sources": [
            "STRING"
          ],
          "validated": false,
          "evidenceCount": 3,
          "evidenceTypes": [
            {
              "type": "experiments",
              "score": 0.526,
              "sources": 1
            },
            {
              "type": "databases",
              "score": 0.7,
              "sources": 1
            },
            {
              "type": "textmining",
              "score": 0.982,
              "sources": 1
            }
          ]
        },
        {
          "gene": "SNCA",
          "partner": "CALM3",
          "partnerName": "Unknown protein",
          "confidence": 0.001,
          "confidenceLevel": "low",
          "sources": [
            "STRING"
          ],
          "validated": false,
          "evidenceCount": 2,
          "evidenceTypes": [
            {
              "type": "experiments",
              "score": 0.903,
              "sources": 1
            },
            {
              "type": "textmining",
              "score": 0.917,
              "sources": 1
            }
          ]
        },
        {
          "gene": "SNCA",
          "partner": "PRKN",
          "partnerName": "Unknown protein",
          "confidence": 0.001,
          "confidenceLevel": "low",
          "sources": [
            "STRING"
          ],
          "validated": false,
          "evidenceCount": 2,
          "evidenceTypes": [
            {
              "type": "experiments",
              "score": 0.457,
              "sources": 1
            },
            {
              "type": "textmining",
              "score": 0.983,
              "sources": 1
            }
          ]
        },
        {
          "gene": "SNCA",
          "partner": "TOMM20",
          "partnerName": "Unknown protein",
          "confidence": 0.001,
          "confidenceLevel": "low",
          "sources": [
            "STRING"
          ],
          "validated": false,
          "evidenceCount": 2,
          "evidenceTypes": [
            {
              "type": "experiments",
              "score": 0.292,
              "sources": 1
            },
            {
              "type": "textmining",
              "score": 0.963,
              "sources": 1
            }
          ]
        },
        {
          "gene": "SNCA",
          "partner": "VDAC1",
          "partnerName": "Unknown protein",
          "confidence": 0.001,
          "confidenceLevel": "low",
          "sources": [
            "STRING"
          ],
          "validated": false,
          "evidenceCount": 2,
          "evidenceTypes": [
            {
              "type": "experiments",
              "score": 0.292,
              "sources": 1
            },
            {
              "type": "textmining",
              "score": 0.949,
              "sources": 1
            }
          ]
        },
        {
          "gene": "SNCA",
          "partner": "CALM1",
          "partnerName": "Unknown protein",
          "confidence": 0.001,
          "confidenceLevel": "low",
          "sources": [
            "STRING"
          ],
          "validated": false,
          "evidenceCount": 2,
          "evidenceTypes": [
            {
              "type": "experiments",
              "score": 0.943,
              "sources": 1
            },
            {
              "type": "textmining",
              "score": 0.349,
              "sources": 1
            }
          ]
        },
        {
          "gene": "SNCA",
          "partner": "APOE",
          "partnerName": "Unknown protein",
          "confidence": 0.001,
          "confidenceLevel": "low",
          "sources": [
            "STRING"
          ],
          "validated": false,
          "evidenceCount": 2,
          "evidenceTypes": [
            {
              "type": "experiments",
              "score": 0.691,
              "sources": 1
            },
            {
              "type": "textmining",
              "score": 0.843,
              "sources": 1
            }
          ]
        },
        {
          "gene": "SNCA",
          "partner": "HSPA4",
          "partnerName": "Unknown protein",
          "confidence": 0.001,
          "confidenceLevel": "low",
          "sources": [
            "STRING"
          ],
          "validated": false,
          "evidenceCount": 2,
          "evidenceTypes": [
            {
              "type": "experiments",
              "score": 0.457,
              "sources": 1
            },
            {
              "type": "textmining",
              "score": 0.875,
              "sources": 1
            }
          ]
        },
        {
          "gene": "SNCA",
          "partner": "HSPA8",
          "partnerName": "Unknown protein",
          "confidence": 0.001,
          "confidenceLevel": "low",
          "sources": [
            "STRING"
          ],
          "validated": false,
          "evidenceCount": 2,
          "evidenceTypes": [
            {
              "type": "experiments",
              "score": 0.457,
              "sources": 1
            },
            {
              "type": "textmining",
              "score": 0.873,
              "sources": 1
            }
          ]
        },
        {
          "gene": "SNCA",
          "partner": "USP9X",
          "partnerName": "Unknown protein",
          "confidence": 0.001,
          "confidenceLevel": "low",
          "sources": [
            "STRING"
          ],
          "validated": false,
          "evidenceCount": 2,
          "evidenceTypes": [
            {
              "type": "experiments",
              "score": 0.292,
              "sources": 1
            },
            {
              "type": "databases",
              "score": 0.9,
              "sources": 1
            }
          ]
        }
      ],
      "networkHubs": [
        {
          "gene": "LRRK2",
          "centrality": 1
        },
        {
          "gene": "SNCA",
          "centrality": 1
        },
        {
          "gene": "PARK7",
          "centrality": 0.7142857142857143
        },
        {
          "gene": "ATP13A2",
          "centrality": 0.5714285714285714
        },
        {
          "gene": "GBA",
          "centrality": 0.5714285714285714
        }
      ],
      "networkImageUrl": "https://string-db.org/api/image/network?identifiers=LRRK2%0APARK7%0ASNCA&species=9606&required_score=700&network_flavor=confidence&hide_disconnected_nodes=1"
    },
    "network3DData": {
      "nodes": [
        {
          "id": "LRRK2",
          "name": "Unknown protein",
          "group": 0,
          "importance": 0.95,
          "val": 15,
          "isPrimary": true,
          "isHub": true,
          "centrality": 1
        },
        {
          "id": "PARK7",
          "name": "Parkinson disease protein 7 homolog",
          "group": 0,
          "importance": 0.7642857142857142,
          "val": 10.714285714285715,
          "isPrimary": true,
          "isHub": true,
          "centrality": 0.7142857142857143
        },
        {
          "id": "SNCA",
          "name": "Alpha-synuclein",
          "group": 0,
          "importance": 0.95,
          "val": 15,
          "isPrimary": true,
          "isHub": true,
          "centrality": 1
        },
        {
          "id": "SNCAIP",
          "name": "SNCAIP",
          "group": 1,
          "importance": 0.3,
          "val": 6.428571428571428,
          "isPrimary": false,
          "isHub": true,
          "centrality": 0.42857142857142855
        },
        {
          "id": "CALM3",
          "name": "CALM3",
          "group": 1,
          "importance": 0.3,
          "val": 5,
          "isPrimary": false
        },
        {
          "id": "PRKN",
          "name": "PRKN",
          "group": 1,
          "importance": 0.3,
          "val": 5,
          "isPrimary": false
        },
        {
          "id": "TOMM20",
          "name": "TOMM20",
          "group": 1,
          "importance": 0.3,
          "val": 5,
          "isPrimary": false
        },
        {
          "id": "VDAC1",
          "name": "VDAC1",
          "group": 1,
          "importance": 0.3,
          "val": 5,
          "isPrimary": false
        },
        {
          "id": "CALM1",
          "name": "CALM1",
          "group": 1,
          "importance": 0.3,
          "val": 5,
          "isPrimary": false
        },
        {
          "id": "APOE",
          "name": "APOE",
          "group": 1,
          "importance": 0.3,
          "val": 5,
          "isPrimary": false
        },
        {
          "id": "HSPA4",
          "name": "HSPA4",
          "group": 1,
          "importance": 0.3,
          "val": 5,
          "isPrimary": false
        },
        {
          "id": "HSPA8",
          "name": "HSPA8",
          "group": 1,
          "importance": 0.3,
          "val": 5,
          "isPrimary": false
        },
        {
          "id": "USP9X",
          "name": "USP9X",
          "group": 1,
          "importance": 0.3,
          "val": 5,
          "isPrimary": false
        },
        {
          "id": "RAB29",
          "name": "RAB29",
          "group": 1,
          "importance": 0.3,
          "val": 4.285714285714286,
          "isPrimary": false,
          "isHub": true,
          "centrality": 0.2857142857142857
        },
        {
          "id": "SFN",
          "name": "SFN",
          "group": 1,
          "importance": 0.3,
          "val": 5,
          "isPrimary": false
        },
        {
          "id": "PTK6",
          "name": "PTK6",
          "group": 1,
          "importance": 0.3,
          "val": 5,
          "isPrimary": false
        },
        {
          "id": "GAK",
          "name": "GAK",
          "group": 1,
          "importance": 0.3,
          "val": 5,
          "isPrimary": false
        },
        {
          "id": "GSK3B",
          "name": "GSK3B",
          "group": 1,
          "importance": 0.3,
          "val": 5,
          "isPrimary": false
        },
        {
          "id": "LRP6",
          "name": "LRP6",
          "group": 1,
          "importance": 0.3,
          "val": 5,
          "isPrimary": false
        },
        {
          "id": "MFN1",
          "name": "MFN1",
          "group": 1,
          "importance": 0.3,
          "val": 5,
          "isPrimary": false
        },
        {
          "id": "CTNNB1",
          "name": "CTNNB1",
          "group": 1,
          "importance": 0.3,
          "val": 5,
          "isPrimary": false
        },
        {
          "id": "PINK1",
          "name": "PINK1",
          "group": 1,
          "importance": 0.3,
          "val": 5,
          "isPrimary": false
        },
        {
          "id": "HSPA9",
          "name": "HSPA9",
          "group": 1,
          "importance": 0.3,
          "val": 5,
          "isPrimary": false
        },
        {
          "id": "EFCAB6",
          "name": "EFCAB6",
          "group": 1,
          "importance": 0.3,
          "val": 5,
          "isPrimary": false
        },
        {
          "id": "OTUD7B",
          "name": "OTUD7B",
          "group": 1,
          "importance": 0.3,
          "val": 5,
          "isPrimary": false
        },
        {
          "id": "NCL",
          "name": "NCL",
          "group": 1,
          "importance": 0.3,
          "val": 5,
          "isPrimary": false
        },
        {
          "id": "NCF1",
          "name": "NCF1",
          "group": 1,
          "importance": 0.3,
          "val": 5,
          "isPrimary": false
        }
      ],
      "links": [
        {
          "source": "SNCA",
          "target": "SNCAIP",
          "value": 0.001,
          "label": "0% confidence",
          "discoveryYear": 2025,
          "evidencePapers": [],
          "evidenceCount": 0,
          "evidenceScore": 0
        },
        {
          "source": "SNCA",
          "target": "CALM3",
          "value": 0.001,
          "label": "0% confidence",
          "discoveryYear": 2025,
          "evidencePapers": [],
          "evidenceCount": 0,
          "evidenceScore": 0
        },
        {
          "source": "SNCA",
          "target": "PRKN",
          "value": 0.001,
          "label": "0% confidence",
          "discoveryYear": 2024,
          "evidencePapers": [
            {
              "pmid": "39074992",
              "title": "Parkinson's disease variant detection and disclosure: PD GENEration, a North American study.",
              "year": 2024,
              "citationCount": 58,
              "influentialCitationCount": 2,
              "studyType": "mixed",
              "studyDesign": null,
              "sampleSize": 510,
              "evidencePolarity": "neutral",
              "journalTier": "tier3",
              "trialPhase": null,
              "isRetracted": false,
              "evidenceScore": 6.24
            },
            {
              "pmid": "39945455",
              "title": "[Parkinson's disease: from genetics to targeted therapies].",
              "year": 2025,
              "citationCount": 0,
              "influentialCitationCount": 0,
              "studyType": "review",
              "studyDesign": null,
              "sampleSize": null,
              "evidencePolarity": "neutral",
              "journalTier": "tier3",
              "trialPhase": null,
              "isRetracted": false,
              "evidenceScore": 1.1
            }
          ],
          "evidenceCount": 2,
          "evidenceScore": 3.67
        },
        {
          "source": "SNCA",
          "target": "TOMM20",
          "value": 0.001,
          "label": "0% confidence",
          "discoveryYear": 2025,
          "evidencePapers": [],
          "evidenceCount": 0,
          "evidenceScore": 0
        },
        {
          "source": "SNCA",
          "target": "VDAC1",
          "value": 0.001,
          "label": "0% confidence",
          "discoveryYear": 2025,
          "evidencePapers": [],
          "evidenceCount": 0,
          "evidenceScore": 0
        },
        {
          "source": "SNCA",
          "target": "CALM1",
          "value": 0.001,
          "label": "0% confidence",
          "discoveryYear": 2024,
          "evidencePapers": [],
          "evidenceCount": 0,
          "evidenceScore": 0
        },
        {
          "source": "SNCA",
          "target": "APOE",
          "value": 0.001,
          "label": "0% confidence",
          "discoveryYear": 2023,
          "evidencePapers": [],
          "evidenceCount": 0,
          "evidenceScore": 0
        },
        {
          "source": "SNCA",
          "target": "HSPA4",
          "value": 0.001,
          "label": "0% confidence",
          "discoveryYear": 2025,
          "evidencePapers": [],
          "evidenceCount": 0,
          "evidenceScore": 0
        },
        {
          "source": "SNCA",
          "target": "HSPA8",
          "value": 0.001,
          "label": "0% confidence",
          "discoveryYear": 2025,
          "evidencePapers": [],
          "evidenceCount": 0,
          "evidenceScore": 0
        },
        {
          "source": "SNCA",
          "target": "USP9X",
          "value": 0.001,
          "label": "0% confidence",
          "discoveryYear": 2023,
          "evidencePapers": [],
          "evidenceCount": 0,
          "evidenceScore": 0
        },
        {
          "source": "LRRK2",
          "target": "RAB29",
          "value": 0.001,
          "label": "0% confidence",
          "discoveryYear": 2025,
          "evidencePapers": [
            {
              "pmid": "39799347",
              "title": "Possible linking and treatment between Parkinson's disease and inflammatory bowel disease: a study of Mendelian randomization based on gut-brain axis.",
              "year": 2025,
              "citationCount": 3,
              "influentialCitationCount": 0,
              "studyType": "meta-analysis",
              "studyDesign": "meta-analysis",
              "sampleSize": null,
              "evidencePolarity": "neutral",
              "journalTier": "tier3",
              "trialPhase": null,
              "isRetracted": false,
              "evidenceScore": 3.02
            }
          ],
          "evidenceCount": 1,
          "evidenceScore": 3.02
        },
        {
          "source": "LRRK2",
          "target": "SFN",
          "value": 0.001,
          "label": "0% confidence",
          "discoveryYear": 2025,
          "evidencePapers": [],
          "evidenceCount": 0,
          "evidenceScore": 0
        },
        {
          "source": "LRRK2",
          "target": "PTK6",
          "value": 0.001,
          "label": "0% confidence",
          "discoveryYear": 2024,
          "evidencePapers": [],
          "evidenceCount": 0,
          "evidenceScore": 0
        },
        {
          "source": "LRRK2",
          "target": "GAK",
          "value": 0.001,
          "label": "0% confidence",
          "discoveryYear": 2025,
          "evidencePapers": [],
          "evidenceCount": 0,
          "evidenceScore": 0
        },
        {
          "source": "LRRK2",
          "target": "GSK3B",
          "value": 0.001,
          "label": "0% confidence",
          "discoveryYear": 2023,
          "evidencePapers": [],
          "evidenceCount": 0,
          "evidenceScore": 0
        },
        {
          "source": "LRRK2",
          "target": "LRP6",
          "value": 0.001,
          "label": "0% confidence",
          "discoveryYear": 2023,
          "evidencePapers": [],
          "evidenceCount": 0,
          "evidenceScore": 0
        },
        {
          "source": "LRRK2",
          "target": "PARK7",
          "value": 0.001,
          "label": "0% confidence",
          "discoveryYear": 2024,
          "evidencePapers": [
            {
              "pmid": "39074992",
              "title": "Parkinson's disease variant detection and disclosure: PD GENEration, a North American study.",
              "year": 2024,
              "citationCount": 58,
              "influentialCitationCount": 2,
              "studyType": "mixed",
              "studyDesign": null,
              "sampleSize": 510,
              "evidencePolarity": "neutral",
              "journalTier": "tier3",
              "trialPhase": null,
              "isRetracted": false,
              "evidenceScore": 6.24
            }
          ],
          "evidenceCount": 1,
          "evidenceScore": 6.24
        },
        {
          "source": "LRRK2",
          "target": "MFN1",
          "value": 0.001,
          "label": "0% confidence",
          "discoveryYear": 2025,
          "evidencePapers": [],
          "evidenceCount": 0,
          "evidenceScore": 0
        },
        {
          "source": "LRRK2",
          "target": "CTNNB1",
          "value": 0.001,
          "label": "0% confidence",
          "discoveryYear": 2023,
          "evidencePapers": [],
          "evidenceCount": 0,
          "evidenceScore": 0
        },
        {
          "source": "LRRK2",
          "target": "PRKN",
          "value": 0.001,
          "label": "0% confidence",
          "discoveryYear": 2024,
          "evidencePapers": [
            {
              "pmid": "39074992",
              "title": "Parkinson's disease variant detection and disclosure: PD GENEration, a North American study.",
              "year": 2024,
              "citationCount": 58,
              "influentialCitationCount": 2,
              "studyType": "mixed",
              "studyDesign": null,
              "sampleSize": 510,
              "evidencePolarity": "neutral",
              "journalTier": "tier3",
              "trialPhase": null,
              "isRetracted": false,
              "evidenceScore": 6.24
            },
            {
              "pmid": "39945455",
              "title": "[Parkinson's disease: from genetics to targeted therapies].",
              "year": 2025,
              "citationCount": 0,
              "influentialCitationCount": 0,
              "studyType": "review",
              "studyDesign": null,
              "sampleSize": null,
              "evidencePolarity": "neutral",
              "journalTier": "tier3",
              "trialPhase": null,
              "isRetracted": false,
              "evidenceScore": 1.1
            }
          ],
          "evidenceCount": 2,
          "evidenceScore": 3.67
        },
        {
          "source": "PARK7",
          "target": "PINK1",
          "value": 0.001,
          "label": "0% confidence",
          "discoveryYear": 2024,
          "evidencePapers": [
            {
              "pmid": "39074992",
              "title": "Parkinson's disease variant detection and disclosure: PD GENEration, a North American study.",
              "year": 2024,
              "citationCount": 58,
              "influentialCitationCount": 2,
              "studyType": "mixed",
              "studyDesign": null,
              "sampleSize": 510,
              "evidencePolarity": "neutral",
              "journalTier": "tier3",
              "trialPhase": null,
              "isRetracted": false,
              "evidenceScore": 6.24
            }
          ],
          "evidenceCount": 1,
          "evidenceScore": 6.24
        },
        {
          "source": "PARK7",
          "target": "HSPA9",
          "value": 0.001,
          "label": "0% confidence",
          "discoveryYear": 2023,
          "evidencePapers": [],
          "evidenceCount": 0,
          "evidenceScore": 0
        },
        {
          "source": "PARK7",
          "target": "PRKN",
          "value": 0.001,
          "label": "0% confidence",
          "discoveryYear": 2024,
          "evidencePapers": [
            {
              "pmid": "39074992",
              "title": "Parkinson's disease variant detection and disclosure: PD GENEration, a North American study.",
              "year": 2024,
              "citationCount": 58,
              "influentialCitationCount": 2,
              "studyType": "mixed",
              "studyDesign": null,
              "sampleSize": 510,
              "evidencePolarity": "neutral",
              "journalTier": "tier3",
              "trialPhase": null,
              "isRetracted": false,
              "evidenceScore": 6.24
            }
          ],
          "evidenceCount": 1,
          "evidenceScore": 6.24
        },
        {
          "source": "PARK7",
          "target": "HSPA4",
          "value": 0.001,
          "label": "0% confidence",
          "discoveryYear": 2023,
          "evidencePapers": [],
          "evidenceCount": 0,
          "evidenceScore": 0
        },
        {
          "source": "PARK7",
          "target": "EFCAB6",
          "value": 0.001,
          "label": "0% confidence",
          "discoveryYear": 2024,
          "evidencePapers": [],
          "evidenceCount": 0,
          "evidenceScore": 0
        },
        {
          "source": "PARK7",
          "target": "SNCA",
          "value": 0.001,
          "label": "0% confidence",
          "discoveryYear": 2024,
          "evidencePapers": [
            {
              "pmid": "39074992",
              "title": "Parkinson's disease variant detection and disclosure: PD GENEration, a North American study.",
              "year": 2024,
              "citationCount": 58,
              "influentialCitationCount": 2,
              "studyType": "mixed",
              "studyDesign": null,
              "sampleSize": 510,
              "evidencePolarity": "neutral",
              "journalTier": "tier3",
              "trialPhase": null,
              "isRetracted": false,
              "evidenceScore": 6.24
            }
          ],
          "evidenceCount": 1,
          "evidenceScore": 6.24
        },
        {
          "source": "PARK7",
          "target": "OTUD7B",
          "value": 0.001,
          "label": "0% confidence",
          "discoveryYear": 2023,
          "evidencePapers": [],
          "evidenceCount": 0,
          "evidenceScore": 0
        },
        {
          "source": "PARK7",
          "target": "NCL",
          "value": 0.001,
          "label": "0% confidence",
          "discoveryYear": 2025,
          "evidencePapers": [],
          "evidenceCount": 0,
          "evidenceScore": 0
        },
        {
          "source": "PARK7",
          "target": "NCF1",
          "value": 0.001,
          "label": "0% confidence",
          "discoveryYear": 2024,
          "evidencePapers": [],
          "evidenceCount": 0,
          "evidenceScore": 0
        }
      ],
      "stats": {
        "totalNodes": 27,
        "totalLinks": 29,
        "avgConfidence": "0.00",
        "hubCount": 5
      }
    },
    "clinical": {
      "totalAssociations": 0,
      "avgScore": 0,
      "highConfidence": 0,
      "topAssociations": [],
      "sharedDiseases": []
    },
    "drugs": {
      "totalCompounds": 79,
      "totalApproved": 0,
      "avgPotency": 7.75,
      "phaseDistribution": {
        "approved": 7,
        "phase3": 0,
        "phase2": 0,
        "phase1": 51,
        "preclinical": 0
      },
      "topCompounds": [
        {
          "name": "PALBOCICLIB",
          "chemblId": "rxcui:1601374",
          "maxPhase": 4,
          "phaseLabel": "FDA Approved",
          "pChEMBL": null,
          "potency": "Interaction: Unknown",
          "sources": [
            "DGIdb"
          ],
          "validated": "single-source",
          "sourceCount": 1,
          "pmids": [],
          "genes": [
            "LRRK2"
          ],
          "targets": [
            "LRRK2"
          ],
          "approvalStatus": "approved",
          "isApproved": true,
          "gene": "LRRK2",
          "source": "DGIdb",
          "targetId": null,
          "targetsMultipleGenes": false,
          "pubchem": {
            "cid": 5330286,
            "molecularWeight": "447.5",
            "xlogp": 1.8,
            "inchikey": "AHJRHEGDXFFMBM-UHFFFAOYSA-N",
            "iupacName": "6-acetyl-8-cyclopentyl-5-methyl-2-[(5-piperazin-1-yl-2-pyridinyl)amino]pyrido[2,3-d]pyrimidin-7-one",
            "source": "PubChem"
          }
        },
        {
          "name": "VANDETANIB",
          "chemblId": "rxcui:1098413",
          "maxPhase": 4,
          "phaseLabel": "FDA Approved",
          "pChEMBL": null,
          "potency": "Interaction: Unknown",
          "sources": [
            "DGIdb"
          ],
          "validated": "single-source",
          "sourceCount": 1,
          "pmids": [],
          "genes": [
            "LRRK2"
          ],
          "targets": [
            "LRRK2"
          ],
          "approvalStatus": "approved",
          "isApproved": true,
          "gene": "LRRK2",
          "source": "DGIdb",
          "targetId": null,
          "targetsMultipleGenes": false,
          "pubchem": {
            "cid": 3081361,
            "molecularWeight": "475.4",
            "xlogp": 4.9,
            "inchikey": "UHTHHESEBZOYNR-UHFFFAOYSA-N",
            "iupacName": "N-(4-bromo-2-fluorophenyl)-6-methoxy-7-[(1-methylpiperidin-4-yl)methoxy]quinazolin-4-amine",
            "source": "PubChem"
          }
        },
        {
          "name": "ENTRECTINIB",
          "chemblId": "rxcui:2197862",
          "maxPhase": 4,
          "phaseLabel": "FDA Approved",
          "pChEMBL": null,
          "potency": "Interaction: Unknown",
          "sources": [
            "DGIdb"
          ],
          "validated": "single-source",
          "sourceCount": 1,
          "pmids": [],
          "genes": [
            "LRRK2"
          ],
          "targets": [
            "LRRK2"
          ],
          "approvalStatus": "approved",
          "isApproved": true,
          "gene": "LRRK2",
          "source": "DGIdb",
          "targetId": null,
          "targetsMultipleGenes": false,
          "pubchem": {
            "cid": 25141092,
            "molecularWeight": "560.6",
            "xlogp": 5.7,
            "inchikey": "HAYYBYPASCDWEQ-UHFFFAOYSA-N",
            "iupacName": "N-[5-[(3,5-difluorophenyl)methyl]-1H-indazol-3-yl]-4-(4-methylpiperazin-1-yl)-2-(oxan-4-ylamino)benzamide",
            "source": "PubChem"
          }
        },
        {
          "name": "GENTIAN VIOLET CATION",
          "chemblId": "rxcui:1546369",
          "maxPhase": 4,
          "phaseLabel": "FDA Approved",
          "pChEMBL": null,
          "potency": "Interaction: Unknown",
          "sources": [
            "DGIdb"
          ],
          "validated": "single-source",
          "sourceCount": 1,
          "pmids": [],
          "genes": [
            "SNCA"
          ],
          "targets": [
            "SNCA"
          ],
          "approvalStatus": "approved",
          "isApproved": true,
          "gene": "SNCA",
          "source": "DGIdb",
          "targetId": null,
          "targetsMultipleGenes": false,
          "pubchem": {
            "cid": 3468,
            "molecularWeight": "372.5",
            "xlogp": 4.9,
            "inchikey": "LGLFFNDHMLKUMI-UHFFFAOYSA-N",
            "iupacName": "[4-[bis[4-(dimethylamino)phenyl]methylidene]cyclohexa-2,5-dien-1-ylidene]-dimethylazanium",
            "source": "PubChem"
          }
        },
        {
          "name": "MYCOPHENOLATE",
          "chemblId": "rxcui:265323",
          "maxPhase": 4,
          "phaseLabel": "FDA Approved",
          "pChEMBL": null,
          "potency": "Interaction: Unknown",
          "sources": [
            "DGIdb"
          ],
          "validated": "single-source",
          "sourceCount": 1,
          "pmids": [],
          "genes": [
            "SNCA"
          ],
          "targets": [
            "SNCA"
          ],
          "approvalStatus": "approved",
          "isApproved": true,
          "gene": "SNCA",
          "source": "DGIdb",
          "targetId": null,
          "targetsMultipleGenes": false,
          "pubchem": {
            "cid": 6918995,
            "molecularWeight": "319.3",
            "xlogp": 3.8,
            "inchikey": "HPNSFSBZBAHARI-RUDMXATFSA-M",
            "iupacName": "(E)-6-(4-hydroxy-6-methoxy-7-methyl-3-oxo-1H-2-benzofuran-5-yl)-4-methylhex-4-enoate",
            "source": "PubChem"
          }
        },
        {
          "name": "DOXORUBICIN HYDROCHLORIDE",
          "chemblId": "rxcui:142433",
          "maxPhase": 4,
          "phaseLabel": "FDA Approved",
          "pChEMBL": null,
          "potency": "Interaction: Unknown",
          "sources": [
            "DGIdb"
          ],
          "validated": "single-source",
          "sourceCount": 1,
          "pmids": [],
          "genes": [
            "SNCA"
          ],
          "targets": [
            "SNCA"
          ],
          "approvalStatus": "approved",
          "isApproved": true,
          "gene": "SNCA",
          "source": "DGIdb",
          "targetId": null,
          "targetsMultipleGenes": false,
          "pubchem": {
            "cid": 443939,
            "molecularWeight": "580.0",
            "inchikey": "MWWSFMDVAYGXBV-RUELKSSGSA-N",
            "iupacName": "(7S,9S)-7-[(2R,4S,5S,6S)-4-amino-5-hydroxy-6-methyloxan-2-yl]oxy-6,9,11-trihydroxy-9-(2-hydroxyacetyl)-4-methoxy-8,10-dihydro-7H-tetracene-5,12-dione;hydrochloride",
            "source": "PubChem"
          }
        },
        {
          "name": "KETOCONAZOLE",
          "chemblId": "rxcui:6135",
          "maxPhase": 4,
          "phaseLabel": "FDA Approved",
          "pChEMBL": null,
          "potency": "Interaction: Unknown",
          "sources": [
            "DGIdb"
          ],
          "validated": "single-source",
          "sourceCount": 1,
          "pmids": [],
          "genes": [
            "SNCA"
          ],
          "targets": [
            "SNCA"
          ],
          "approvalStatus": "approved",
          "isApproved": true,
          "gene": "SNCA",
          "source": "DGIdb",
          "targetId": null,
          "targetsMultipleGenes": false,
          "pubchem": {
            "cid": 47576,
            "molecularWeight": "531.4",
            "xlogp": 4.3,
            "inchikey": "XMAYWYJOQHXEEK-ZEQKJWHPSA-N",
            "iupacName": "1-[4-[4-[[(2S,4R)-2-(2,4-dichlorophenyl)-2-(imidazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]piperazin-1-yl]ethanone",
            "source": "PubChem"
          }
        },
        {
          "name": "ADAVOSERTIB",
          "chemblId": "ncit:C91725",
          "maxPhase": 1,
          "phaseLabel": "Phase 1",
          "pChEMBL": null,
          "potency": "Interaction: Unknown",
          "sources": [
            "DGIdb"
          ],
          "validated": "single-source",
          "sourceCount": 1,
          "pmids": [],
          "genes": [
            "LRRK2"
          ],
          "targets": [
            "LRRK2"
          ],
          "approvalStatus": "investigational",
          "isApproved": false,
          "gene": "LRRK2",
          "source": "DGIdb",
          "targetId": null,
          "targetsMultipleGenes": false,
          "pubchem": {
            "cid": 24856436,
            "molecularWeight": "500.6",
            "xlogp": 3.1,
            "inchikey": "BKWJAKQVGHWELA-UHFFFAOYSA-N",
            "iupacName": "1-[6-(2-hydroxypropan-2-yl)-2-pyridinyl]-6-[4-(4-methylpiperazin-1-yl)anilino]-2-prop-2-enylpyrazolo[3,4-d]pyrimidin-3-one",
            "source": "PubChem"
          }
        },
        {
          "name": "AST-487",
          "chemblId": "iuphar.ligand:5661",
          "maxPhase": 1,
          "phaseLabel": "Phase 1",
          "pChEMBL": null,
          "potency": "Interaction: Unknown",
          "sources": [
            "DGIdb"
          ],
          "validated": "single-source",
          "sourceCount": 1,
          "pmids": [],
          "genes": [
            "LRRK2"
          ],
          "targets": [
            "LRRK2"
          ],
          "approvalStatus": "investigational",
          "isApproved": false,
          "gene": "LRRK2",
          "source": "DGIdb",
          "targetId": null,
          "targetsMultipleGenes": false,
          "pubchem": {
            "cid": 11409972,
            "molecularWeight": "529.6",
            "xlogp": 3.8,
            "inchikey": "ODPGGGTTYSGTGO-UHFFFAOYSA-N",
            "iupacName": "1-[4-[(4-ethylpiperazin-1-yl)methyl]-3-(trifluoromethyl)phenyl]-3-[4-[6-(methylamino)pyrimidin-4-yl]oxyphenyl]urea",
            "source": "PubChem"
          }
        },
        {
          "name": "PICTILISIB",
          "chemblId": "ncit:C165479",
          "maxPhase": 1,
          "phaseLabel": "Phase 1",
          "pChEMBL": null,
          "potency": "Interaction: Unknown",
          "sources": [
            "DGIdb"
          ],
          "validated": "single-source",
          "sourceCount": 1,
          "pmids": [],
          "genes": [
            "LRRK2"
          ],
          "targets": [
            "LRRK2"
          ],
          "approvalStatus": "investigational",
          "isApproved": false,
          "gene": "LRRK2",
          "source": "DGIdb",
          "targetId": null,
          "targetsMultipleGenes": false,
          "pubchem": {
            "cid": 17755052,
            "molecularWeight": "513.6",
            "xlogp": 1.6,
            "inchikey": "LHNIIDJUOCFXAP-UHFFFAOYSA-N",
            "iupacName": "4-[2-(1H-indazol-4-yl)-6-[(4-methylsulfonylpiperazin-1-yl)methyl]thieno[3,2-d]pyrimidin-4-yl]morpholine",
            "source": "PubChem"
          }
        }
      ],
      "approvedDrugs": [],
      "multiTargetCompounds": []
    },
    "drugRepurposing": {
      "candidates": [
        {
          "drug": "PALBOCICLIB",
          "drugId": "rxcui:1601374",
          "repurposingScore": 45,
          "confidence": "medium",
          "breakdown": {
            "targetMatch": 33.33333333333333,
            "pathwayOverlap": 0,
            "clinicalEvidence": 100,
            "safetyProfile": 100,
            "mechanismRelevance": 0
          },
          "matchedTargets": [
            "LRRK2"
          ],
          "currentIndication": "Unknown",
          "proposedIndication": "Parkinson's disease",
          "mechanism": "Not specified",
          "phase": "FDA Approved",
          "estimatedSavings": {
            "cost": "$1035M - $1535M",
            "time": "8 - 10 years faster",
            "confidence": "medium"
          },
          "reasoning": [
            "⚠️ Partial target match (33%)",
            "✅ FDA approved with proven safety profile"
          ]
        },
        {
          "drug": "VANDETANIB",
          "drugId": "rxcui:1098413",
          "repurposingScore": 45,
          "confidence": "medium",
          "breakdown": {
            "targetMatch": 33.33333333333333,
            "pathwayOverlap": 0,
            "clinicalEvidence": 100,
            "safetyProfile": 100,
            "mechanismRelevance": 0
          },
          "matchedTargets": [
            "LRRK2"
          ],
          "currentIndication": "Unknown",
          "proposedIndication": "Parkinson's disease",
          "mechanism": "Not specified",
          "phase": "FDA Approved",
          "estimatedSavings": {
            "cost": "$1035M - $1535M",
            "time": "8 - 10 years faster",
            "confidence": "medium"
          },
          "reasoning": [
            "⚠️ Partial target match (33%)",
            "✅ FDA approved with proven safety profile"
          ]
        },
        {
          "drug": "ENTRECTINIB",
          "drugId": "rxcui:2197862",
          "repurposingScore": 45,
          "confidence": "medium",
          "breakdown": {
            "targetMatch": 33.33333333333333,
            "pathwayOverlap": 0,
            "clinicalEvidence": 100,
            "safetyProfile": 100,
            "mechanismRelevance": 0
          },
          "matchedTargets": [
            "LRRK2"
          ],
          "currentIndication": "Unknown",
          "proposedIndication": "Parkinson's disease",
          "mechanism": "Not specified",
          "phase": "FDA Approved",
          "estimatedSavings": {
            "cost": "$1035M - $1535M",
            "time": "8 - 10 years faster",
            "confidence": "medium"
          },
          "reasoning": [
            "⚠️ Partial target match (33%)",
            "✅ FDA approved with proven safety profile"
          ]
        },
        {
          "drug": "GENTIAN VIOLET CATION",
          "drugId": "rxcui:1546369",
          "repurposingScore": 45,
          "confidence": "medium",
          "breakdown": {
            "targetMatch": 33.33333333333333,
            "pathwayOverlap": 0,
            "clinicalEvidence": 100,
            "safetyProfile": 100,
            "mechanismRelevance": 0
          },
          "matchedTargets": [
            "SNCA"
          ],
          "currentIndication": "Unknown",
          "proposedIndication": "Parkinson's disease",
          "mechanism": "Not specified",
          "phase": "FDA Approved",
          "estimatedSavings": {
            "cost": "$1035M - $1535M",
            "time": "8 - 10 years faster",
            "confidence": "medium"
          },
          "reasoning": [
            "⚠️ Partial target match (33%)",
            "✅ FDA approved with proven safety profile"
          ]
        },
        {
          "drug": "MYCOPHENOLATE",
          "drugId": "rxcui:265323",
          "repurposingScore": 45,
          "confidence": "medium",
          "breakdown": {
            "targetMatch": 33.33333333333333,
            "pathwayOverlap": 0,
            "clinicalEvidence": 100,
            "safetyProfile": 100,
            "mechanismRelevance": 0
          },
          "matchedTargets": [
            "SNCA"
          ],
          "currentIndication": "Unknown",
          "proposedIndication": "Parkinson's disease",
          "mechanism": "Not specified",
          "phase": "FDA Approved",
          "estimatedSavings": {
            "cost": "$1035M - $1535M",
            "time": "8 - 10 years faster",
            "confidence": "medium"
          },
          "reasoning": [
            "⚠️ Partial target match (33%)",
            "✅ FDA approved with proven safety profile"
          ]
        },
        {
          "drug": "DOXORUBICIN HYDROCHLORIDE",
          "drugId": "rxcui:142433",
          "repurposingScore": 45,
          "confidence": "medium",
          "breakdown": {
            "targetMatch": 33.33333333333333,
            "pathwayOverlap": 0,
            "clinicalEvidence": 100,
            "safetyProfile": 100,
            "mechanismRelevance": 0
          },
          "matchedTargets": [
            "SNCA"
          ],
          "currentIndication": "Unknown",
          "proposedIndication": "Parkinson's disease",
          "mechanism": "Not specified",
          "phase": "FDA Approved",
          "estimatedSavings": {
            "cost": "$1035M - $1535M",
            "time": "8 - 10 years faster",
            "confidence": "medium"
          },
          "reasoning": [
            "⚠️ Partial target match (33%)",
            "✅ FDA approved with proven safety profile"
          ]
        },
        {
          "drug": "KETOCONAZOLE",
          "drugId": "rxcui:6135",
          "repurposingScore": 45,
          "confidence": "medium",
          "breakdown": {
            "targetMatch": 33.33333333333333,
            "pathwayOverlap": 0,
            "clinicalEvidence": 100,
            "safetyProfile": 100,
            "mechanismRelevance": 0
          },
          "matchedTargets": [
            "SNCA"
          ],
          "currentIndication": "Unknown",
          "proposedIndication": "Parkinson's disease",
          "mechanism": "Not specified",
          "phase": "FDA Approved",
          "estimatedSavings": {
            "cost": "$1035M - $1535M",
            "time": "8 - 10 years faster",
            "confidence": "medium"
          },
          "reasoning": [
            "⚠️ Partial target match (33%)",
            "✅ FDA approved with proven safety profile"
          ]
        }
      ],
      "stats": {
        "totalDrugsAnalyzed": 79,
        "candidatesFound": 7,
        "avgScore": 45,
        "analysisTime": "0ms",
        "minScore": 30,
        "onlyApproved": false
      },
      "summary": {
        "headline": "7 drug repurposing candidates identified for Parkinson's disease",
        "summary": "Top candidate: PALBOCICLIB (45% match). 7 FDA-approved drugs found.",
        "recommendation": "Prioritize PALBOCICLIB for experimental validation. Estimated savings: $1035M - $1535M vs. new drug development.",
        "commercialValue": "Enterprise feature worth $10K-50K/year. Total potential savings across 7 candidates: $10500M - $17500M."
      },
      "enterpriseValue": "$10K-50K/year",
      "timestamp": "2026-01-16T13:35:29.502Z"
    },
    "novelHypotheses": {
      "hypotheses": [
        {
          "type": "drug_repurposing",
          "statement": "PALBOCICLIB may be repurposed to treat Parkinson's disease",
          "drug": "PALBOCICLIB",
          "drugId": "rxcui:1601374",
          "disease": "Parkinson's disease",
          "currentIndication": "Unknown",
          "mechanism": "Targets LRRK2 which are implicated in disease",
          "score": 0.9923076923076923,
          "evidence": [
            {
              "type": "target_overlap",
              "gene": "LRRK2",
              "description": "Drug targets gene associated with disease",
              "weight": 0.6
            },
            {
              "type": "target_overlap",
              "gene": "LRRK2",
              "description": "Drug targets gene associated with disease",
              "weight": 0.6
            },
            {
              "type": "target_overlap",
              "gene": "LRRK2",
              "description": "Drug targets gene associated with disease",
              "weight": 0.6
            },
            {
              "type": "target_overlap",
              "gene": "LRRK2",
              "description": "Drug targets gene associated with disease",
              "weight": 0.6
            },
            {
              "type": "target_overlap",
              "gene": "LRRK2",
              "description": "Drug targets gene associated with disease",
              "weight": 0.6
            },
            {
              "type": "target_overlap",
              "gene": "LRRK2",
              "description": "Drug targets gene associated with disease",
              "weight": 0.6
            },
            {
              "type": "target_overlap",
              "gene": "LRRK2",
              "description": "Drug targets gene associated with disease",
              "weight": 0.6
            },
            {
              "type": "target_overlap",
              "gene": "LRRK2",
              "description": "Drug targets gene associated with disease",
              "weight": 0.6
            },
            {
              "type": "target_overlap",
              "gene": "LRRK2",
              "description": "Drug targets gene associated with disease",
              "weight": 0.6
            },
            {
              "type": "target_overlap",
              "gene": "LRRK2",
              "description": "Drug targets gene associated with disease",
              "weight": 0.6
            },
            {
              "type": "target_overlap",
              "gene": "LRRK2",
              "description": "Drug targets gene associated with disease",
              "weight": 0.6
            },
            {
              "type": "target_overlap",
              "gene": "LRRK2",
              "description": "Drug targets gene associated with disease",
              "weight": 0.6
            },
            {
              "type": "target_overlap",
              "gene": "LRRK2",
              "description": "Drug targets gene associated with disease",
              "weight": 0.6
            },
            {
              "type": "target_overlap",
              "gene": "LRRK2",
              "description": "Drug targets gene associated with disease",
              "weight": 0.6
            },
            {
              "type": "target_overlap",
              "gene": "LRRK2",
              "description": "Drug targets gene associated with disease",
              "weight": 0.6
            },
            {
              "type": "target_overlap",
              "gene": "LRRK2",
              "description": "Drug targets gene associated with disease",
              "weight": 0.6
            },
            {
              "type": "target_overlap",
              "gene": "LRRK2",
              "description": "Drug targets gene associated with disease",
              "weight": 0.6
            },
            {
              "type": "target_overlap",
              "gene": "LRRK2",
              "description": "Drug targets gene associated with disease",
              "weight": 0.6
            }
          ],
          "supportingEvidence": 0,
          "contradictingEvidence": 0,
          "evidenceBalance": 0,
          "novelty": 0.85,
          "testable": true,
          "clinicalPhase": 4,
          "approved": true,
          "confidence": 0.8984615384615384,
          "impact": 0.95,
          "plausibility": 0.8578461538461539,
          "evidenceStrength": 1,
          "contradictionPenalty": 0,
          "supportingEvidenceItems": [],
          "contradictingEvidenceItems": [],
          "mixedEvidenceItems": [],
          "neutralEvidenceItems": [
            {
              "type": "target_overlap",
              "gene": "LRRK2",
              "description": "Drug targets gene associated with disease",
              "weight": 0.6
            },
            {
              "type": "target_overlap",
              "gene": "LRRK2",
              "description": "Drug targets gene associated with disease",
              "weight": 0.6
            },
            {
              "type": "target_overlap",
              "gene": "LRRK2",
              "description": "Drug targets gene associated with disease",
              "weight": 0.6
            },
            {
              "type": "target_overlap",
              "gene": "LRRK2",
              "description": "Drug targets gene associated with disease",
              "weight": 0.6
            },
            {
              "type": "target_overlap",
              "gene": "LRRK2",
              "description": "Drug targets gene associated with disease",
              "weight": 0.6
            },
            {
              "type": "target_overlap",
              "gene": "LRRK2",
              "description": "Drug targets gene associated with disease",
              "weight": 0.6
            },
            {
              "type": "target_overlap",
              "gene": "LRRK2",
              "description": "Drug targets gene associated with disease",
              "weight": 0.6
            },
            {
              "type": "target_overlap",
              "gene": "LRRK2",
              "description": "Drug targets gene associated with disease",
              "weight": 0.6
            },
            {
              "type": "target_overlap",
              "gene": "LRRK2",
              "description": "Drug targets gene associated with disease",
              "weight": 0.6
            },
            {
              "type": "target_overlap",
              "gene": "LRRK2",
              "description": "Drug targets gene associated with disease",
              "weight": 0.6
            },
            {
              "type": "target_overlap",
              "gene": "LRRK2",
              "description": "Drug targets gene associated with disease",
              "weight": 0.6
            },
            {
              "type": "target_overlap",
              "gene": "LRRK2",
              "description": "Drug targets gene associated with disease",
              "weight": 0.6
            },
            {
              "type": "target_overlap",
              "gene": "LRRK2",
              "description": "Drug targets gene associated with disease",
              "weight": 0.6
            },
            {
              "type": "target_overlap",
              "gene": "LRRK2",
              "description": "Drug targets gene associated with disease",
              "weight": 0.6
            },
            {
              "type": "target_overlap",
              "gene": "LRRK2",
              "description": "Drug targets gene associated with disease",
              "weight": 0.6
            },
            {
              "type": "target_overlap",
              "gene": "LRRK2",
              "description": "Drug targets gene associated with disease",
              "weight": 0.6
            },
            {
              "type": "target_overlap",
              "gene": "LRRK2",
              "description": "Drug targets gene associated with disease",
              "weight": 0.6
            },
            {
              "type": "target_overlap",
              "gene": "LRRK2",
              "description": "Drug targets gene associated with disease",
              "weight": 0.6
            }
          ],
          "supportingPmids": [],
          "contradictingPmids": [],
          "noveltyRationale": "Highly novel; limited direct literature links, multi-source evidence support.",
          "noveltySignals": {
            "directEvidenceScore": 0,
            "evidenceStrength": 1,
            "supportingEvidence": 0,
            "contradictingEvidence": 0
          },
          "totalScore": 0.8931384615384614,
          "scorecard": {
            "confidence": 0.8984615384615384,
            "novelty": 0.85,
            "impact": 0.95,
            "plausibility": 0.8578461538461539,
            "evidenceStrength": 1,
            "contradictionPenalty": 0,
            "supporting": 0,
            "contradicting": 0,
            "mixed": 0,
            "neutral": 18,
            "supportWeight": 0,
            "contradictWeight": 0
          },
          "rank": 1,
          "experimentalDesign": {
            "hypothesis": "PALBOCICLIB may be repurposed to treat Parkinson's disease",
            "experimentType": "In Vitro Efficacy + Mechanism Validation",
            "protocol": [
              "1. Select disease-relevant cell lines or organoids for Parkinson's disease",
              "2. Treat with PALBOCICLIB across a dose range (8-12 concentrations)",
              "3. Measure viability, apoptosis, and pathway biomarkers at 24h/72h",
              "4. Validate on-target engagement with western blot or target-specific assays"
            ],
            "controls": [
              "Vehicle control (DMSO)",
              "Known standard-of-care drug (positive control)",
              "Off-target negative control compound"
            ],
            "readouts": [
              "Dose-response curve and IC50",
              "Biomarker modulation (pathway activation/inhibition)",
              "Cell cycle profiling (flow cytometry)",
              "Transcriptomic response signature"
            ],
            "timeline": "3-6 weeks",
            "estimatedCost": "$10,000-20,000",
            "successCriteria": "Significant efficacy vs control with IC50 < 1 μM and biomarker modulation",
            "predictedOutcome": "90% probability of efficacy",
            "expectedOutcome": "Exploratory outcome; limited direct evidence in current graph."
          },
          "id": "a163bc9d58579f84",
          "shareUrl": "http://localhost:8787/hypothesis/a163bc9d58579f84",
          "reportValidationUrl": "http://localhost:8787/api/validate/a163bc9d58579f84"
        },
        {
          "type": "drug_repurposing",
          "statement": "VANDETANIB may be repurposed to treat Parkinson's disease",
          "drug": "VANDETANIB",
          "drugId": "rxcui:1098413",
          "disease": "Parkinson's disease",
          "currentIndication": "Unknown",
          "mechanism": "Targets LRRK2 which are implicated in disease",
          "score": 0.9923076923076923,
          "evidence": [
            {
              "type": "target_overlap",
              "gene": "LRRK2",
              "description": "Drug targets gene associated with disease",
              "weight": 0.6
            },
            {
              "type": "target_overlap",
              "gene": "LRRK2",
              "description": "Drug targets gene associated with disease",
              "weight": 0.6
            },
            {
              "type": "target_overlap",
              "gene": "LRRK2",
              "description": "Drug targets gene associated with disease",
              "weight": 0.6
            },
            {
              "type": "target_overlap",
              "gene": "LRRK2",
              "description": "Drug targets gene associated with disease",
              "weight": 0.6
            },
            {
              "type": "target_overlap",
              "gene": "LRRK2",
              "description": "Drug targets gene associated with disease",
              "weight": 0.6
            },
            {
              "type": "target_overlap",
              "gene": "LRRK2",
              "description": "Drug targets gene associated with disease",
              "weight": 0.6
            },
            {
              "type": "target_overlap",
              "gene": "LRRK2",
              "description": "Drug targets gene associated with disease",
              "weight": 0.6
            },
            {
              "type": "target_overlap",
              "gene": "LRRK2",
              "description": "Drug targets gene associated with disease",
              "weight": 0.6
            },
            {
              "type": "target_overlap",
              "gene": "LRRK2",
              "description": "Drug targets gene associated with disease",
              "weight": 0.6
            },
            {
              "type": "target_overlap",
              "gene": "LRRK2",
              "description": "Drug targets gene associated with disease",
              "weight": 0.6
            },
            {
              "type": "target_overlap",
              "gene": "LRRK2",
              "description": "Drug targets gene associated with disease",
              "weight": 0.6
            },
            {
              "type": "target_overlap",
              "gene": "LRRK2",
              "description": "Drug targets gene associated with disease",
              "weight": 0.6
            },
            {
              "type": "target_overlap",
              "gene": "LRRK2",
              "description": "Drug targets gene associated with disease",
              "weight": 0.6
            },
            {
              "type": "target_overlap",
              "gene": "LRRK2",
              "description": "Drug targets gene associated with disease",
              "weight": 0.6
            },
            {
              "type": "target_overlap",
              "gene": "LRRK2",
              "description": "Drug targets gene associated with disease",
              "weight": 0.6
            },
            {
              "type": "target_overlap",
              "gene": "LRRK2",
              "description": "Drug targets gene associated with disease",
              "weight": 0.6
            },
            {
              "type": "target_overlap",
              "gene": "LRRK2",
              "description": "Drug targets gene associated with disease",
              "weight": 0.6
            },
            {
              "type": "target_overlap",
              "gene": "LRRK2",
              "description": "Drug targets gene associated with disease",
              "weight": 0.6
            }
          ],
          "supportingEvidence": 0,
          "contradictingEvidence": 0,
          "evidenceBalance": 0,
          "novelty": 0.85,
          "testable": true,
          "clinicalPhase": 4,
          "approved": true,
          "confidence": 0.8984615384615384,
          "impact": 0.95,
          "plausibility": 0.8578461538461539,
          "evidenceStrength": 1,
          "contradictionPenalty": 0,
          "supportingEvidenceItems": [],
          "contradictingEvidenceItems": [],
          "mixedEvidenceItems": [],
          "neutralEvidenceItems": [
            {
              "type": "target_overlap",
              "gene": "LRRK2",
              "description": "Drug targets gene associated with disease",
              "weight": 0.6
            },
            {
              "type": "target_overlap",
              "gene": "LRRK2",
              "description": "Drug targets gene associated with disease",
              "weight": 0.6
            },
            {
              "type": "target_overlap",
              "gene": "LRRK2",
              "description": "Drug targets gene associated with disease",
              "weight": 0.6
            },
            {
              "type": "target_overlap",
              "gene": "LRRK2",
              "description": "Drug targets gene associated with disease",
              "weight": 0.6
            },
            {
              "type": "target_overlap",
              "gene": "LRRK2",
              "description": "Drug targets gene associated with disease",
              "weight": 0.6
            },
            {
              "type": "target_overlap",
              "gene": "LRRK2",
              "description": "Drug targets gene associated with disease",
              "weight": 0.6
            },
            {
              "type": "target_overlap",
              "gene": "LRRK2",
              "description": "Drug targets gene associated with disease",
              "weight": 0.6
            },
            {
              "type": "target_overlap",
              "gene": "LRRK2",
              "description": "Drug targets gene associated with disease",
              "weight": 0.6
            },
            {
              "type": "target_overlap",
              "gene": "LRRK2",
              "description": "Drug targets gene associated with disease",
              "weight": 0.6
            },
            {
              "type": "target_overlap",
              "gene": "LRRK2",
              "description": "Drug targets gene associated with disease",
              "weight": 0.6
            },
            {
              "type": "target_overlap",
              "gene": "LRRK2",
              "description": "Drug targets gene associated with disease",
              "weight": 0.6
            },
            {
              "type": "target_overlap",
              "gene": "LRRK2",
              "description": "Drug targets gene associated with disease",
              "weight": 0.6
            },
            {
              "type": "target_overlap",
              "gene": "LRRK2",
              "description": "Drug targets gene associated with disease",
              "weight": 0.6
            },
            {
              "type": "target_overlap",
              "gene": "LRRK2",
              "description": "Drug targets gene associated with disease",
              "weight": 0.6
            },
            {
              "type": "target_overlap",
              "gene": "LRRK2",
              "description": "Drug targets gene associated with disease",
              "weight": 0.6
            },
            {
              "type": "target_overlap",
              "gene": "LRRK2",
              "description": "Drug targets gene associated with disease",
              "weight": 0.6
            },
            {
              "type": "target_overlap",
              "gene": "LRRK2",
              "description": "Drug targets gene associated with disease",
              "weight": 0.6
            },
            {
              "type": "target_overlap",
              "gene": "LRRK2",
              "description": "Drug targets gene associated with disease",
              "weight": 0.6
            }
          ],
          "supportingPmids": [],
          "contradictingPmids": [],
          "noveltyRationale": "Highly novel; limited direct literature links, multi-source evidence support.",
          "noveltySignals": {
            "directEvidenceScore": 0,
            "evidenceStrength": 1,
            "supportingEvidence": 0,
            "contradictingEvidence": 0
          },
          "totalScore": 0.8931384615384614,
          "scorecard": {
            "confidence": 0.8984615384615384,
            "novelty": 0.85,
            "impact": 0.95,
            "plausibility": 0.8578461538461539,
            "evidenceStrength": 1,
            "contradictionPenalty": 0,
            "supporting": 0,
            "contradicting": 0,
            "mixed": 0,
            "neutral": 18,
            "supportWeight": 0,
            "contradictWeight": 0
          },
          "rank": 2,
          "experimentalDesign": {
            "hypothesis": "VANDETANIB may be repurposed to treat Parkinson's disease",
            "experimentType": "In Vitro Efficacy + Mechanism Validation",
            "protocol": [
              "1. Select disease-relevant cell lines or organoids for Parkinson's disease",
              "2. Treat with VANDETANIB across a dose range (8-12 concentrations)",
              "3. Measure viability, apoptosis, and pathway biomarkers at 24h/72h",
              "4. Validate on-target engagement with western blot or target-specific assays"
            ],
            "controls": [
              "Vehicle control (DMSO)",
              "Known standard-of-care drug (positive control)",
              "Off-target negative control compound"
            ],
            "readouts": [
              "Dose-response curve and IC50",
              "Biomarker modulation (pathway activation/inhibition)",
              "Cell cycle profiling (flow cytometry)",
              "Transcriptomic response signature"
            ],
            "timeline": "3-6 weeks",
            "estimatedCost": "$10,000-20,000",
            "successCriteria": "Significant efficacy vs control with IC50 < 1 μM and biomarker modulation",
            "predictedOutcome": "90% probability of efficacy",
            "expectedOutcome": "Exploratory outcome; limited direct evidence in current graph."
          },
          "id": "fb64a298cfc9fe7f",
          "shareUrl": "http://localhost:8787/hypothesis/fb64a298cfc9fe7f",
          "reportValidationUrl": "http://localhost:8787/api/validate/fb64a298cfc9fe7f"
        },
        {
          "type": "drug_repurposing",
          "statement": "ENTRECTINIB may be repurposed to treat Parkinson's disease",
          "drug": "ENTRECTINIB",
          "drugId": "rxcui:2197862",
          "disease": "Parkinson's disease",
          "currentIndication": "Unknown",
          "mechanism": "Targets LRRK2 which are implicated in disease",
          "score": 0.9923076923076923,
          "evidence": [
            {
              "type": "target_overlap",
              "gene": "LRRK2",
              "description": "Drug targets gene associated with disease",
              "weight": 0.6
            },
            {
              "type": "target_overlap",
              "gene": "LRRK2",
              "description": "Drug targets gene associated with disease",
              "weight": 0.6
            },
            {
              "type": "target_overlap",
              "gene": "LRRK2",
              "description": "Drug targets gene associated with disease",
              "weight": 0.6
            },
            {
              "type": "target_overlap",
              "gene": "LRRK2",
              "description": "Drug targets gene associated with disease",
              "weight": 0.6
            },
            {
              "type": "target_overlap",
              "gene": "LRRK2",
              "description": "Drug targets gene associated with disease",
              "weight": 0.6
            },
            {
              "type": "target_overlap",
              "gene": "LRRK2",
              "description": "Drug targets gene associated with disease",
              "weight": 0.6
            },
            {
              "type": "target_overlap",
              "gene": "LRRK2",
              "description": "Drug targets gene associated with disease",
              "weight": 0.6
            },
            {
              "type": "target_overlap",
              "gene": "LRRK2",
              "description": "Drug targets gene associated with disease",
              "weight": 0.6
            },
            {
              "type": "target_overlap",
              "gene": "LRRK2",
              "description": "Drug targets gene associated with disease",
              "weight": 0.6
            },
            {
              "type": "target_overlap",
              "gene": "LRRK2",
              "description": "Drug targets gene associated with disease",
              "weight": 0.6
            },
            {
              "type": "target_overlap",
              "gene": "LRRK2",
              "description": "Drug targets gene associated with disease",
              "weight": 0.6
            },
            {
              "type": "target_overlap",
              "gene": "LRRK2",
              "description": "Drug targets gene associated with disease",
              "weight": 0.6
            },
            {
              "type": "target_overlap",
              "gene": "LRRK2",
              "description": "Drug targets gene associated with disease",
              "weight": 0.6
            },
            {
              "type": "target_overlap",
              "gene": "LRRK2",
              "description": "Drug targets gene associated with disease",
              "weight": 0.6
            },
            {
              "type": "target_overlap",
              "gene": "LRRK2",
              "description": "Drug targets gene associated with disease",
              "weight": 0.6
            },
            {
              "type": "target_overlap",
              "gene": "LRRK2",
              "description": "Drug targets gene associated with disease",
              "weight": 0.6
            },
            {
              "type": "target_overlap",
              "gene": "LRRK2",
              "description": "Drug targets gene associated with disease",
              "weight": 0.6
            },
            {
              "type": "target_overlap",
              "gene": "LRRK2",
              "description": "Drug targets gene associated with disease",
              "weight": 0.6
            }
          ],
          "supportingEvidence": 0,
          "contradictingEvidence": 0,
          "evidenceBalance": 0,
          "novelty": 0.85,
          "testable": true,
          "clinicalPhase": 4,
          "approved": true,
          "confidence": 0.8984615384615384,
          "impact": 0.95,
          "plausibility": 0.8578461538461539,
          "evidenceStrength": 1,
          "contradictionPenalty": 0,
          "supportingEvidenceItems": [],
          "contradictingEvidenceItems": [],
          "mixedEvidenceItems": [],
          "neutralEvidenceItems": [
            {
              "type": "target_overlap",
              "gene": "LRRK2",
              "description": "Drug targets gene associated with disease",
              "weight": 0.6
            },
            {
              "type": "target_overlap",
              "gene": "LRRK2",
              "description": "Drug targets gene associated with disease",
              "weight": 0.6
            },
            {
              "type": "target_overlap",
              "gene": "LRRK2",
              "description": "Drug targets gene associated with disease",
              "weight": 0.6
            },
            {
              "type": "target_overlap",
              "gene": "LRRK2",
              "description": "Drug targets gene associated with disease",
              "weight": 0.6
            },
            {
              "type": "target_overlap",
              "gene": "LRRK2",
              "description": "Drug targets gene associated with disease",
              "weight": 0.6
            },
            {
              "type": "target_overlap",
              "gene": "LRRK2",
              "description": "Drug targets gene associated with disease",
              "weight": 0.6
            },
            {
              "type": "target_overlap",
              "gene": "LRRK2",
              "description": "Drug targets gene associated with disease",
              "weight": 0.6
            },
            {
              "type": "target_overlap",
              "gene": "LRRK2",
              "description": "Drug targets gene associated with disease",
              "weight": 0.6
            },
            {
              "type": "target_overlap",
              "gene": "LRRK2",
              "description": "Drug targets gene associated with disease",
              "weight": 0.6
            },
            {
              "type": "target_overlap",
              "gene": "LRRK2",
              "description": "Drug targets gene associated with disease",
              "weight": 0.6
            },
            {
              "type": "target_overlap",
              "gene": "LRRK2",
              "description": "Drug targets gene associated with disease",
              "weight": 0.6
            },
            {
              "type": "target_overlap",
              "gene": "LRRK2",
              "description": "Drug targets gene associated with disease",
              "weight": 0.6
            },
            {
              "type": "target_overlap",
              "gene": "LRRK2",
              "description": "Drug targets gene associated with disease",
              "weight": 0.6
            },
            {
              "type": "target_overlap",
              "gene": "LRRK2",
              "description": "Drug targets gene associated with disease",
              "weight": 0.6
            },
            {
              "type": "target_overlap",
              "gene": "LRRK2",
              "description": "Drug targets gene associated with disease",
              "weight": 0.6
            },
            {
              "type": "target_overlap",
              "gene": "LRRK2",
              "description": "Drug targets gene associated with disease",
              "weight": 0.6
            },
            {
              "type": "target_overlap",
              "gene": "LRRK2",
              "description": "Drug targets gene associated with disease",
              "weight": 0.6
            },
            {
              "type": "target_overlap",
              "gene": "LRRK2",
              "description": "Drug targets gene associated with disease",
              "weight": 0.6
            }
          ],
          "supportingPmids": [],
          "contradictingPmids": [],
          "noveltyRationale": "Highly novel; limited direct literature links, multi-source evidence support.",
          "noveltySignals": {
            "directEvidenceScore": 0,
            "evidenceStrength": 1,
            "supportingEvidence": 0,
            "contradictingEvidence": 0
          },
          "totalScore": 0.8931384615384614,
          "scorecard": {
            "confidence": 0.8984615384615384,
            "novelty": 0.85,
            "impact": 0.95,
            "plausibility": 0.8578461538461539,
            "evidenceStrength": 1,
            "contradictionPenalty": 0,
            "supporting": 0,
            "contradicting": 0,
            "mixed": 0,
            "neutral": 18,
            "supportWeight": 0,
            "contradictWeight": 0
          },
          "rank": 3,
          "experimentalDesign": {
            "hypothesis": "ENTRECTINIB may be repurposed to treat Parkinson's disease",
            "experimentType": "In Vitro Efficacy + Mechanism Validation",
            "protocol": [
              "1. Select disease-relevant cell lines or organoids for Parkinson's disease",
              "2. Treat with ENTRECTINIB across a dose range (8-12 concentrations)",
              "3. Measure viability, apoptosis, and pathway biomarkers at 24h/72h",
              "4. Validate on-target engagement with western blot or target-specific assays"
            ],
            "controls": [
              "Vehicle control (DMSO)",
              "Known standard-of-care drug (positive control)",
              "Off-target negative control compound"
            ],
            "readouts": [
              "Dose-response curve and IC50",
              "Biomarker modulation (pathway activation/inhibition)",
              "Cell cycle profiling (flow cytometry)",
              "Transcriptomic response signature"
            ],
            "timeline": "3-6 weeks",
            "estimatedCost": "$10,000-20,000",
            "successCriteria": "Significant efficacy vs control with IC50 < 1 μM and biomarker modulation",
            "predictedOutcome": "90% probability of efficacy",
            "expectedOutcome": "Exploratory outcome; limited direct evidence in current graph."
          },
          "id": "95ff7e4ee462b6f8",
          "shareUrl": "http://localhost:8787/hypothesis/95ff7e4ee462b6f8",
          "reportValidationUrl": "http://localhost:8787/api/validate/95ff7e4ee462b6f8"
        },
        {
          "type": "drug_repurposing",
          "statement": "ADAVOSERTIB may be repurposed to treat Parkinson's disease",
          "drug": "ADAVOSERTIB",
          "drugId": "ncit:C91725",
          "disease": "Parkinson's disease",
          "currentIndication": "Unknown",
          "mechanism": "Targets LRRK2 which are implicated in disease",
          "score": 0.9923076923076923,
          "evidence": [
            {
              "type": "target_overlap",
              "gene": "LRRK2",
              "description": "Drug targets gene associated with disease",
              "weight": 0.6
            },
            {
              "type": "target_overlap",
              "gene": "LRRK2",
              "description": "Drug targets gene associated with disease",
              "weight": 0.6
            },
            {
              "type": "target_overlap",
              "gene": "LRRK2",
              "description": "Drug targets gene associated with disease",
              "weight": 0.6
            },
            {
              "type": "target_overlap",
              "gene": "LRRK2",
              "description": "Drug targets gene associated with disease",
              "weight": 0.6
            },
            {
              "type": "target_overlap",
              "gene": "LRRK2",
              "description": "Drug targets gene associated with disease",
              "weight": 0.6
            },
            {
              "type": "target_overlap",
              "gene": "LRRK2",
              "description": "Drug targets gene associated with disease",
              "weight": 0.6
            },
            {
              "type": "target_overlap",
              "gene": "LRRK2",
              "description": "Drug targets gene associated with disease",
              "weight": 0.6
            },
            {
              "type": "target_overlap",
              "gene": "LRRK2",
              "description": "Drug targets gene associated with disease",
              "weight": 0.6
            },
            {
              "type": "target_overlap",
              "gene": "LRRK2",
              "description": "Drug targets gene associated with disease",
              "weight": 0.6
            },
            {
              "type": "target_overlap",
              "gene": "LRRK2",
              "description": "Drug targets gene associated with disease",
              "weight": 0.6
            },
            {
              "type": "target_overlap",
              "gene": "LRRK2",
              "description": "Drug targets gene associated with disease",
              "weight": 0.6
            },
            {
              "type": "target_overlap",
              "gene": "LRRK2",
              "description": "Drug targets gene associated with disease",
              "weight": 0.6
            },
            {
              "type": "target_overlap",
              "gene": "LRRK2",
              "description": "Drug targets gene associated with disease",
              "weight": 0.6
            },
            {
              "type": "target_overlap",
              "gene": "LRRK2",
              "description": "Drug targets gene associated with disease",
              "weight": 0.6
            },
            {
              "type": "target_overlap",
              "gene": "LRRK2",
              "description": "Drug targets gene associated with disease",
              "weight": 0.6
            },
            {
              "type": "target_overlap",
              "gene": "LRRK2",
              "description": "Drug targets gene associated with disease",
              "weight": 0.6
            },
            {
              "type": "target_overlap",
              "gene": "LRRK2",
              "description": "Drug targets gene associated with disease",
              "weight": 0.6
            },
            {
              "type": "target_overlap",
              "gene": "LRRK2",
              "description": "Drug targets gene associated with disease",
              "weight": 0.6
            }
          ],
          "supportingEvidence": 0,
          "contradictingEvidence": 0,
          "evidenceBalance": 0,
          "novelty": 0.85,
          "testable": true,
          "clinicalPhase": 1,
          "approved": false,
          "confidence": 0.8984615384615384,
          "impact": 0.8,
          "plausibility": 0.8578461538461539,
          "evidenceStrength": 1,
          "contradictionPenalty": 0,
          "supportingEvidenceItems": [],
          "contradictingEvidenceItems": [],
          "mixedEvidenceItems": [],
          "neutralEvidenceItems": [
            {
              "type": "target_overlap",
              "gene": "LRRK2",
              "description": "Drug targets gene associated with disease",
              "weight": 0.6
            },
            {
              "type": "target_overlap",
              "gene": "LRRK2",
              "description": "Drug targets gene associated with disease",
              "weight": 0.6
            },
            {
              "type": "target_overlap",
              "gene": "LRRK2",
              "description": "Drug targets gene associated with disease",
              "weight": 0.6
            },
            {
              "type": "target_overlap",
              "gene": "LRRK2",
              "description": "Drug targets gene associated with disease",
              "weight": 0.6
            },
            {
              "type": "target_overlap",
              "gene": "LRRK2",
              "description": "Drug targets gene associated with disease",
              "weight": 0.6
            },
            {
              "type": "target_overlap",
              "gene": "LRRK2",
              "description": "Drug targets gene associated with disease",
              "weight": 0.6
            },
            {
              "type": "target_overlap",
              "gene": "LRRK2",
              "description": "Drug targets gene associated with disease",
              "weight": 0.6
            },
            {
              "type": "target_overlap",
              "gene": "LRRK2",
              "description": "Drug targets gene associated with disease",
              "weight": 0.6
            },
            {
              "type": "target_overlap",
              "gene": "LRRK2",
              "description": "Drug targets gene associated with disease",
              "weight": 0.6
            },
            {
              "type": "target_overlap",
              "gene": "LRRK2",
              "description": "Drug targets gene associated with disease",
              "weight": 0.6
            },
            {
              "type": "target_overlap",
              "gene": "LRRK2",
              "description": "Drug targets gene associated with disease",
              "weight": 0.6
            },
            {
              "type": "target_overlap",
              "gene": "LRRK2",
              "description": "Drug targets gene associated with disease",
              "weight": 0.6
            },
            {
              "type": "target_overlap",
              "gene": "LRRK2",
              "description": "Drug targets gene associated with disease",
              "weight": 0.6
            },
            {
              "type": "target_overlap",
              "gene": "LRRK2",
              "description": "Drug targets gene associated with disease",
              "weight": 0.6
            },
            {
              "type": "target_overlap",
              "gene": "LRRK2",
              "description": "Drug targets gene associated with disease",
              "weight": 0.6
            },
            {
              "type": "target_overlap",
              "gene": "LRRK2",
              "description": "Drug targets gene associated with disease",
              "weight": 0.6
            },
            {
              "type": "target_overlap",
              "gene": "LRRK2",
              "description": "Drug targets gene associated with disease",
              "weight": 0.6
            },
            {
              "type": "target_overlap",
              "gene": "LRRK2",
              "description": "Drug targets gene associated with disease",
              "weight": 0.6
            }
          ],
          "supportingPmids": [],
          "contradictingPmids": [],
          "noveltyRationale": "Highly novel; limited direct literature links, multi-source evidence support.",
          "noveltySignals": {
            "directEvidenceScore": 0,
            "evidenceStrength": 1,
            "supportingEvidence": 0,
            "contradictingEvidence": 0
          },
          "totalScore": 0.8556384615384616,
          "scorecard": {
            "confidence": 0.8984615384615384,
            "novelty": 0.85,
            "impact": 0.8,
            "plausibility": 0.8578461538461539,
            "evidenceStrength": 1,
            "contradictionPenalty": 0,
            "supporting": 0,
            "contradicting": 0,
            "mixed": 0,
            "neutral": 18,
            "supportWeight": 0,
            "contradictWeight": 0
          },
          "rank": 4,
          "experimentalDesign": {
            "hypothesis": "ADAVOSERTIB may be repurposed to treat Parkinson's disease",
            "experimentType": "In Vitro Efficacy + Mechanism Validation",
            "protocol": [
              "1. Select disease-relevant cell lines or organoids for Parkinson's disease",
              "2. Treat with ADAVOSERTIB across a dose range (8-12 concentrations)",
              "3. Measure viability, apoptosis, and pathway biomarkers at 24h/72h",
              "4. Validate on-target engagement with western blot or target-specific assays"
            ],
            "controls": [
              "Vehicle control (DMSO)",
              "Known standard-of-care drug (positive control)",
              "Off-target negative control compound"
            ],
            "readouts": [
              "Dose-response curve and IC50",
              "Biomarker modulation (pathway activation/inhibition)",
              "Cell cycle profiling (flow cytometry)",
              "Transcriptomic response signature"
            ],
            "timeline": "3-6 weeks",
            "estimatedCost": "$10,000-20,000",
            "successCriteria": "Significant efficacy vs control with IC50 < 1 μM and biomarker modulation",
            "predictedOutcome": "90% probability of efficacy",
            "expectedOutcome": "Exploratory outcome; limited direct evidence in current graph."
          },
          "id": "9bd6b34e06de890a",
          "shareUrl": "http://localhost:8787/hypothesis/9bd6b34e06de890a",
          "reportValidationUrl": "http://localhost:8787/api/validate/9bd6b34e06de890a"
        },
        {
          "type": "drug_repurposing",
          "statement": "AST-487 may be repurposed to treat Parkinson's disease",
          "drug": "AST-487",
          "drugId": "iuphar.ligand:5661",
          "disease": "Parkinson's disease",
          "currentIndication": "Unknown",
          "mechanism": "Targets LRRK2 which are implicated in disease",
          "score": 0.9923076923076923,
          "evidence": [
            {
              "type": "target_overlap",
              "gene": "LRRK2",
              "description": "Drug targets gene associated with disease",
              "weight": 0.6
            },
            {
              "type": "target_overlap",
              "gene": "LRRK2",
              "description": "Drug targets gene associated with disease",
              "weight": 0.6
            },
            {
              "type": "target_overlap",
              "gene": "LRRK2",
              "description": "Drug targets gene associated with disease",
              "weight": 0.6
            },
            {
              "type": "target_overlap",
              "gene": "LRRK2",
              "description": "Drug targets gene associated with disease",
              "weight": 0.6
            },
            {
              "type": "target_overlap",
              "gene": "LRRK2",
              "description": "Drug targets gene associated with disease",
              "weight": 0.6
            },
            {
              "type": "target_overlap",
              "gene": "LRRK2",
              "description": "Drug targets gene associated with disease",
              "weight": 0.6
            },
            {
              "type": "target_overlap",
              "gene": "LRRK2",
              "description": "Drug targets gene associated with disease",
              "weight": 0.6
            },
            {
              "type": "target_overlap",
              "gene": "LRRK2",
              "description": "Drug targets gene associated with disease",
              "weight": 0.6
            },
            {
              "type": "target_overlap",
              "gene": "LRRK2",
              "description": "Drug targets gene associated with disease",
              "weight": 0.6
            },
            {
              "type": "target_overlap",
              "gene": "LRRK2",
              "description": "Drug targets gene associated with disease",
              "weight": 0.6
            },
            {
              "type": "target_overlap",
              "gene": "LRRK2",
              "description": "Drug targets gene associated with disease",
              "weight": 0.6
            },
            {
              "type": "target_overlap",
              "gene": "LRRK2",
              "description": "Drug targets gene associated with disease",
              "weight": 0.6
            },
            {
              "type": "target_overlap",
              "gene": "LRRK2",
              "description": "Drug targets gene associated with disease",
              "weight": 0.6
            },
            {
              "type": "target_overlap",
              "gene": "LRRK2",
              "description": "Drug targets gene associated with disease",
              "weight": 0.6
            },
            {
              "type": "target_overlap",
              "gene": "LRRK2",
              "description": "Drug targets gene associated with disease",
              "weight": 0.6
            },
            {
              "type": "target_overlap",
              "gene": "LRRK2",
              "description": "Drug targets gene associated with disease",
              "weight": 0.6
            },
            {
              "type": "target_overlap",
              "gene": "LRRK2",
              "description": "Drug targets gene associated with disease",
              "weight": 0.6
            },
            {
              "type": "target_overlap",
              "gene": "LRRK2",
              "description": "Drug targets gene associated with disease",
              "weight": 0.6
            }
          ],
          "supportingEvidence": 0,
          "contradictingEvidence": 0,
          "evidenceBalance": 0,
          "novelty": 0.85,
          "testable": true,
          "clinicalPhase": 1,
          "approved": false,
          "confidence": 0.8984615384615384,
          "impact": 0.8,
          "plausibility": 0.8578461538461539,
          "evidenceStrength": 1,
          "contradictionPenalty": 0,
          "supportingEvidenceItems": [],
          "contradictingEvidenceItems": [],
          "mixedEvidenceItems": [],
          "neutralEvidenceItems": [
            {
              "type": "target_overlap",
              "gene": "LRRK2",
              "description": "Drug targets gene associated with disease",
              "weight": 0.6
            },
            {
              "type": "target_overlap",
              "gene": "LRRK2",
              "description": "Drug targets gene associated with disease",
              "weight": 0.6
            },
            {
              "type": "target_overlap",
              "gene": "LRRK2",
              "description": "Drug targets gene associated with disease",
              "weight": 0.6
            },
            {
              "type": "target_overlap",
              "gene": "LRRK2",
              "description": "Drug targets gene associated with disease",
              "weight": 0.6
            },
            {
              "type": "target_overlap",
              "gene": "LRRK2",
              "description": "Drug targets gene associated with disease",
              "weight": 0.6
            },
            {
              "type": "target_overlap",
              "gene": "LRRK2",
              "description": "Drug targets gene associated with disease",
              "weight": 0.6
            },
            {
              "type": "target_overlap",
              "gene": "LRRK2",
              "description": "Drug targets gene associated with disease",
              "weight": 0.6
            },
            {
              "type": "target_overlap",
              "gene": "LRRK2",
              "description": "Drug targets gene associated with disease",
              "weight": 0.6
            },
            {
              "type": "target_overlap",
              "gene": "LRRK2",
              "description": "Drug targets gene associated with disease",
              "weight": 0.6
            },
            {
              "type": "target_overlap",
              "gene": "LRRK2",
              "description": "Drug targets gene associated with disease",
              "weight": 0.6
            },
            {
              "type": "target_overlap",
              "gene": "LRRK2",
              "description": "Drug targets gene associated with disease",
              "weight": 0.6
            },
            {
              "type": "target_overlap",
              "gene": "LRRK2",
              "description": "Drug targets gene associated with disease",
              "weight": 0.6
            },
            {
              "type": "target_overlap",
              "gene": "LRRK2",
              "description": "Drug targets gene associated with disease",
              "weight": 0.6
            },
            {
              "type": "target_overlap",
              "gene": "LRRK2",
              "description": "Drug targets gene associated with disease",
              "weight": 0.6
            },
            {
              "type": "target_overlap",
              "gene": "LRRK2",
              "description": "Drug targets gene associated with disease",
              "weight": 0.6
            },
            {
              "type": "target_overlap",
              "gene": "LRRK2",
              "description": "Drug targets gene associated with disease",
              "weight": 0.6
            },
            {
              "type": "target_overlap",
              "gene": "LRRK2",
              "description": "Drug targets gene associated with disease",
              "weight": 0.6
            },
            {
              "type": "target_overlap",
              "gene": "LRRK2",
              "description": "Drug targets gene associated with disease",
              "weight": 0.6
            }
          ],
          "supportingPmids": [],
          "contradictingPmids": [],
          "noveltyRationale": "Highly novel; limited direct literature links, multi-source evidence support.",
          "noveltySignals": {
            "directEvidenceScore": 0,
            "evidenceStrength": 1,
            "supportingEvidence": 0,
            "contradictingEvidence": 0
          },
          "totalScore": 0.8556384615384616,
          "scorecard": {
            "confidence": 0.8984615384615384,
            "novelty": 0.85,
            "impact": 0.8,
            "plausibility": 0.8578461538461539,
            "evidenceStrength": 1,
            "contradictionPenalty": 0,
            "supporting": 0,
            "contradicting": 0,
            "mixed": 0,
            "neutral": 18,
            "supportWeight": 0,
            "contradictWeight": 0
          },
          "rank": 5,
          "experimentalDesign": {
            "hypothesis": "AST-487 may be repurposed to treat Parkinson's disease",
            "experimentType": "In Vitro Efficacy + Mechanism Validation",
            "protocol": [
              "1. Select disease-relevant cell lines or organoids for Parkinson's disease",
              "2. Treat with AST-487 across a dose range (8-12 concentrations)",
              "3. Measure viability, apoptosis, and pathway biomarkers at 24h/72h",
              "4. Validate on-target engagement with western blot or target-specific assays"
            ],
            "controls": [
              "Vehicle control (DMSO)",
              "Known standard-of-care drug (positive control)",
              "Off-target negative control compound"
            ],
            "readouts": [
              "Dose-response curve and IC50",
              "Biomarker modulation (pathway activation/inhibition)",
              "Cell cycle profiling (flow cytometry)",
              "Transcriptomic response signature"
            ],
            "timeline": "3-6 weeks",
            "estimatedCost": "$10,000-20,000",
            "successCriteria": "Significant efficacy vs control with IC50 < 1 μM and biomarker modulation",
            "predictedOutcome": "90% probability of efficacy",
            "expectedOutcome": "Exploratory outcome; limited direct evidence in current graph."
          },
          "id": "e7ea6b6bc7e4fbe2",
          "shareUrl": "http://localhost:8787/hypothesis/e7ea6b6bc7e4fbe2",
          "reportValidationUrl": "http://localhost:8787/api/validate/e7ea6b6bc7e4fbe2"
        }
      ],
      "stats": {
        "candidatesGenerated": 5,
        "hypothesesReturned": 5,
        "avgConfidence": 0.8984615384615384,
        "avgNovelty": 0.85,
        "generationTime": "19ms",
        "graphSize": {
          "nodes": 114,
          "edges": 135
        }
      },
      "metadata": {
        "timestamp": "2026-01-16T13:35:52.498Z",
        "diseaseContext": "Parkinson's disease",
        "geneCount": 3,
        "minConfidence": 0.65,
        "noveltyThreshold": 0.7
      },
      "accuracyStats": {
        "overallAccuracy": 0,
        "totalHypotheses": 466,
        "totalValidations": 0,
        "confirmed": 0,
        "rejected": 0,
        "partial": 0,
        "pending": 0,
        "accuracyByType": {},
        "trustScore": 0,
        "message": "Building trust - Testing predictions in the lab"
      },
      "enterpriseValue": "$100K-500K/year",
      "patentPotential": "HIGH - Novel predictions can be patented",
      "revolutionaryNote": "These predictions go BEYOND existing literature - they are NEW knowledge generated by AI",
      "learningNote": "AI improves with every validation. Current accuracy: 0.0% based on 0 validations"
    },
    "citations": [
      {
        "pmid": "39153957",
        "citation": "Xiong Y, Yu J. LRRK2 in Parkinson's disease: upstream regulation and therapeutic targeting.. Trends in molecular medicine. 2024.",
        "url": "https://pubmed.ncbi.nlm.nih.gov/39153957/"
      },
      {
        "pmid": "38621236",
        "citation": "Alessi DR, Pfeffer SR. Leucine-Rich Repeat Kinases.. Annual review of biochemistry. 2024.",
        "url": "https://pubmed.ncbi.nlm.nih.gov/38621236/"
      },
      {
        "pmid": "39596444",
        "citation": "Arya R, Haque AKMA, Shakya H. Parkinson's Disease: Biomarkers for Diagnosis and Disease Progression.. International journal of molecular sciences. 2024.",
        "url": "https://pubmed.ncbi.nlm.nih.gov/39596444/"
      },
      {
        "pmid": "38391909",
        "citation": "Skou LD, Johansen SK, Okarmus J. Pathogenesis of DJ-1/PARK7-Mediated Parkinson's Disease.. Cells. 2024.",
        "url": "https://pubmed.ncbi.nlm.nih.gov/38391909/"
      },
      {
        "pmid": "38368937",
        "citation": "Alessi DR, Cullen PJ, Cookson M. Retromer-dependent lysosomal stress in Parkinson's disease.. Philosophical transactions of the Royal Society of London. Series B, Biological sciences. 2024.",
        "url": "https://pubmed.ncbi.nlm.nih.gov/38368937/"
      },
      {
        "pmid": "39983584",
        "citation": "Bentley-DeSousa A, Clegg D, Ferguson SM. LRRK2, lysosome damage, and Parkinson's disease.. Current opinion in cell biology. 2025.",
        "url": "https://pubmed.ncbi.nlm.nih.gov/39983584/"
      },
      {
        "pmid": "39029778",
        "citation": "Lal R, Singh A, Watts S. Experimental models of Parkinson's disease: Challenges and Opportunities.. European journal of pharmacology. 2024.",
        "url": "https://pubmed.ncbi.nlm.nih.gov/39029778/"
      },
      {
        "pmid": "38377788",
        "citation": "Kalyanaraman B, Cheng G, Hardy M. Gut microbiome, short-chain fatty acids, alpha-synuclein, neuroinflammation, and ROS/RNS: Relevance to Parkinson's disease and therapeutic implications.. Redox biology. 2024.",
        "url": "https://pubmed.ncbi.nlm.nih.gov/38377788/"
      },
      {
        "pmid": "40914459",
        "citation": "Kim TY, Lee BD. Current therapeutic strategies in Parkinson's disease: Future perspectives.. Molecules and cells. 2025.",
        "url": "https://pubmed.ncbi.nlm.nih.gov/40914459/"
      },
      {
        "pmid": "38438297",
        "citation": "Maayan Eshed G, Alcalay RN. GBA1-and LRRK2-directed Treatments: The Way Forward.. Parkinsonism & related disorders. 2024.",
        "url": "https://pubmed.ncbi.nlm.nih.gov/38438297/"
      },
      {
        "pmid": "40121531",
        "citation": "Szunyogh S, Carroll E, Wade-Martins R. Recent developments in gene therapy for Parkinson's disease.. Molecular therapy : the journal of the American Society of Gene Therapy. 2025.",
        "url": "https://pubmed.ncbi.nlm.nih.gov/40121531/"
      },
      {
        "pmid": "39514635",
        "citation": "Sun S, Hodel M, Wang X. Macrophage LRRK2 hyperactivity impairs autophagy and induces Paneth cell dysfunction.. Science immunology. 2024.",
        "url": "https://pubmed.ncbi.nlm.nih.gov/39514635/"
      },
      {
        "pmid": "39945455",
        "citation": "Cogan G, Brice A. [Parkinson's disease: from genetics to targeted therapies].. Comptes rendus biologies. 2025.",
        "url": "https://pubmed.ncbi.nlm.nih.gov/39945455/"
      },
      {
        "pmid": "38614108",
        "citation": "Gustavsson EK, Follett J, Trinh J. RAB32 Ser71Arg in autosomal dominant Parkinson's disease: linkage, association, and functional analyses.. The Lancet. Neurology. 2024.",
        "url": "https://pubmed.ncbi.nlm.nih.gov/38614108/"
      },
      {
        "pmid": "40440058",
        "citation": "Buck SA, Sanders LH. LRRK2-mediated mitochondrial dysfunction in Parkinson's disease.. The Biochemical journal. 2025.",
        "url": "https://pubmed.ncbi.nlm.nih.gov/40440058/"
      },
      {
        "pmid": "39199337",
        "citation": "Caramiello AM, Pirota V. Novel Therapeutic Horizons:  Targeting in Parkinson's Disease.. Biomolecules. 2024.",
        "url": "https://pubmed.ncbi.nlm.nih.gov/39199337/"
      },
      {
        "pmid": "39167665",
        "citation": "Bido S, Nannoni M, Muggeo S. Microglia-specific  gene delivery inhibits neuroinflammation and neurodegeneration in a mouse model of Parkinson's disease.. Science translational medicine. 2024.",
        "url": "https://pubmed.ncbi.nlm.nih.gov/39167665/"
      },
      {
        "pmid": "39074992",
        "citation": "Cook L, Verbrugge J, Schwantes-An TH. Parkinson's disease variant detection and disclosure: PD GENEration, a North American study.. Brain : a journal of neurology. 2024.",
        "url": "https://pubmed.ncbi.nlm.nih.gov/39074992/"
      },
      {
        "pmid": "38951707",
        "citation": "Agarwal A, Chandran A, Raza F. VAMP2 regulates phase separation of α-synuclein.. Nature cell biology. 2024.",
        "url": "https://pubmed.ncbi.nlm.nih.gov/38951707/"
      },
      {
        "pmid": "40185526",
        "citation": "Maayan Eshed G, Alcalay RN. Precision Medicine in Parkinson's Disease.. Neurologic clinics. 2025.",
        "url": "https://pubmed.ncbi.nlm.nih.gov/40185526/"
      }
    ],
    "citationCounts": {
      "38368937": 5,
      "38377788": 84,
      "38391909": 49,
      "38438297": 7,
      "38614108": 67,
      "38621236": 33,
      "38702933": 4,
      "38951707": 29,
      "39029778": 44,
      "39074992": 58,
      "39153957": 19,
      "39167665": 28,
      "39199337": 7,
      "39514635": 5,
      "39596444": 0,
      "39799347": 3,
      "39812709": 33,
      "39905728": 6,
      "39945455": 0,
      "39962078": 13,
      "39983584": 12,
      "40121531": 4,
      "40185526": 5,
      "40262613": 5,
      "40440058": 3,
      "40626361": 4,
      "40737317": 1,
      "40914459": 2,
      "41083601": 0
    },
    "openAccessMap": {
      "38368937": "https://royalsocietypublishing.org/doi/pdf/10.1098/rstb.2022.0376",
      "38377788": "https://doi.org/10.1016/j.redox.2024.103092",
      "38391909": "https://www.mdpi.com/2073-4409/13/4/296/pdf?version=1707203655",
      "38614108": "http://www.thelancet.com/article/S1474442224001212/pdf",
      "38702933": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11069054",
      "38951707": "https://www.nature.com/articles/s41556-024-01451-6.pdf",
      "39074992": "https://academic.oup.com/brain/article-pdf/147/8/2668/58712400/awae142.pdf",
      "39199337": "https://www.mdpi.com/2218-273X/14/8/949/pdf?version=1722933019",
      "39812709": "https://www.biorxiv.org/content/biorxiv/early/2023/11/01/2023.10.31.564602.full.pdf"
    },
    "leadingResearchers": [
      {
        "name": "Micael Hardy",
        "paperCount": 1,
        "totalCitations": 84,
        "avgCitations": 84,
        "topPaper": {
          "pmid": "38377788",
          "title": "Gut microbiome, short-chain fatty acids, alpha-synuclein, neuroinflammation, and ROS/RNS: Relevance to Parkinson's disease and therapeutic implications.",
          "year": "2024",
          "citationCount": 84
        },
        "role": "Senior Researcher"
      },
      {
        "name": "Balaraman Kalyanaraman",
        "paperCount": 1,
        "totalCitations": 84,
        "avgCitations": 84,
        "topPaper": {
          "pmid": "38377788",
          "title": "Gut microbiome, short-chain fatty acids, alpha-synuclein, neuroinflammation, and ROS/RNS: Relevance to Parkinson's disease and therapeutic implications.",
          "year": "2024",
          "citationCount": 84
        },
        "role": "Active Contributor"
      },
      {
        "name": "Gang Cheng",
        "paperCount": 1,
        "totalCitations": 84,
        "avgCitations": 84,
        "topPaper": {
          "pmid": "38377788",
          "title": "Gut microbiome, short-chain fatty acids, alpha-synuclein, neuroinflammation, and ROS/RNS: Relevance to Parkinson's disease and therapeutic implications.",
          "year": "2024",
          "citationCount": 84
        },
        "role": "Active Contributor"
      },
      {
        "name": "Alex Rajput",
        "paperCount": 2,
        "totalCitations": 134,
        "avgCitations": 67,
        "topPaper": {
          "pmid": "38614108",
          "title": "RAB32 Ser71Arg in autosomal dominant Parkinson's disease: linkage, association, and functional analyses.",
          "year": "2024",
          "citationCount": 67
        },
        "role": "Active Contributor"
      },
      {
        "name": "Matthew J. Farrer",
        "paperCount": 1,
        "totalCitations": 67,
        "avgCitations": 67,
        "topPaper": {
          "pmid": "38614108",
          "title": "RAB32 Ser71Arg in autosomal dominant Parkinson's disease: linkage, association, and functional analyses.",
          "year": "2024",
          "citationCount": 67
        },
        "role": "Senior Researcher"
      },
      {
        "name": "E. Gustavsson",
        "paperCount": 1,
        "totalCitations": 67,
        "avgCitations": 67,
        "topPaper": {
          "pmid": "38614108",
          "title": "RAB32 Ser71Arg in autosomal dominant Parkinson's disease: linkage, association, and functional analyses.",
          "year": "2024",
          "citationCount": 67
        },
        "role": "Active Contributor"
      },
      {
        "name": "J. Follett",
        "paperCount": 1,
        "totalCitations": 67,
        "avgCitations": 67,
        "topPaper": {
          "pmid": "38614108",
          "title": "RAB32 Ser71Arg in autosomal dominant Parkinson's disease: linkage, association, and functional analyses.",
          "year": "2024",
          "citationCount": 67
        },
        "role": "Active Contributor"
      },
      {
        "name": "Joanne Trinh",
        "paperCount": 1,
        "totalCitations": 67,
        "avgCitations": 67,
        "topPaper": {
          "pmid": "38614108",
          "title": "RAB32 Ser71Arg in autosomal dominant Parkinson's disease: linkage, association, and functional analyses.",
          "year": "2024",
          "citationCount": 67
        },
        "role": "Active Contributor"
      },
      {
        "name": "S. K. Barodia",
        "paperCount": 1,
        "totalCitations": 67,
        "avgCitations": 67,
        "topPaper": {
          "pmid": "38614108",
          "title": "RAB32 Ser71Arg in autosomal dominant Parkinson's disease: linkage, association, and functional analyses.",
          "year": "2024",
          "citationCount": 67
        },
        "role": "Active Contributor"
      },
      {
        "name": "R. Real",
        "paperCount": 1,
        "totalCitations": 67,
        "avgCitations": 67,
        "topPaper": {
          "pmid": "38614108",
          "title": "RAB32 Ser71Arg in autosomal dominant Parkinson's disease: linkage, association, and functional analyses.",
          "year": "2024",
          "citationCount": 67
        },
        "role": "Active Contributor"
      }
    ],
    "recommendedPapers": [],
    "totalPapersUsed": 9,
    "evidenceSummary": {
      "totalItems": 3,
      "papersWithEvidence": 2,
      "topItems": [
        {
          "pmid": "38614108",
          "label": "p=0",
          "context": "affected individuals; non-parametric linkage Z score=1·95; p=0·03). 2604 unrelated individuals with Parkinson's disease an"
        },
        {
          "pmid": "38614108",
          "label": "n=16",
          "context": "disease presented at age 54·6 years (SD 12·75, range 31-81, n=16), and two-thirds had a family history of parkinsonism. RAB3"
        },
        {
          "pmid": "39074992",
          "label": "510 participants",
          "context": "Between September 2019 and June 2023, the study enrolled 10 510 participants across >85 centres, with 8301 having received results. Part"
        }
      ]
    },
    "evidenceLedger": {
      "summary": {
        "totalItems": 3,
        "papersWithEvidence": 2,
        "topItems": [
          {
            "pmid": "38614108",
            "label": "p=0",
            "context": "affected individuals; non-parametric linkage Z score=1·95; p=0·03). 2604 unrelated individuals with Parkinson's disease an"
          },
          {
            "pmid": "38614108",
            "label": "n=16",
            "context": "disease presented at age 54·6 years (SD 12·75, range 31-81, n=16), and two-thirds had a family history of parkinsonism. RAB3"
          },
          {
            "pmid": "39074992",
            "label": "510 participants",
            "context": "Between September 2019 and June 2023, the study enrolled 10 510 participants across >85 centres, with 8301 having received results. Part"
          }
        ]
      },
      "papers": [
        {
          "pmid": "39153957",
          "title": "LRRK2 in Parkinson's disease: upstream regulation and therapeutic targeting.",
          "journal": "Trends in molecular medicine",
          "year": "2024",
          "citationCount": 19,
          "influentialCitationCount": 1,
          "isReview": true,
          "studyType": "review",
          "studyDesign": null,
          "sampleSize": null,
          "sampleSizeText": null,
          "openAccessUrl": null,
          "evidencePolarity": "support",
          "evidenceSignals": {
            "supportHits": 1,
            "contradictHits": 0
          },
          "contradictionTags": [],
          "contradictionSummary": null,
          "contradictionSeverity": null,
          "journalTier": "tier3",
          "trialPhase": null,
          "isRetracted": false,
          "evidenceItems": [],
          "evidenceCount": 0,
          "evidenceScore": 3.53,
          "evidenceScoreComponents": {
            "citations": 1.56,
            "influential": 0.27,
            "sampleSize": 0,
            "evidenceItems": 0,
            "evidenceSignals": 0.2,
            "recency": 0.35,
            "studyType": 0.6,
            "studyDesign": 0,
            "polarity": 0.4,
            "journalTier": 0.15,
            "trialPhase": 0,
            "retraction": 0
          }
        },
        {
          "pmid": "38621236",
          "title": "Leucine-Rich Repeat Kinases.",
          "journal": "Annual review of biochemistry",
          "year": "2024",
          "citationCount": 33,
          "influentialCitationCount": 3,
          "isReview": true,
          "studyType": "review",
          "studyDesign": null,
          "sampleSize": null,
          "sampleSizeText": null,
          "openAccessUrl": null,
          "evidencePolarity": "neutral",
          "evidenceSignals": {
            "supportHits": 0,
            "contradictHits": 0
          },
          "contradictionTags": [],
          "contradictionSummary": null,
          "contradictionSeverity": null,
          "journalTier": "tier3",
          "trialPhase": null,
          "isRetracted": false,
          "evidenceItems": [],
          "evidenceCount": 0,
          "evidenceScore": 3.48,
          "evidenceScoreComponents": {
            "citations": 1.84,
            "influential": 0.54,
            "sampleSize": 0,
            "evidenceItems": 0,
            "evidenceSignals": 0,
            "recency": 0.35,
            "studyType": 0.6,
            "studyDesign": 0,
            "polarity": 0,
            "journalTier": 0.15,
            "trialPhase": 0,
            "retraction": 0
          }
        },
        {
          "pmid": "38391909",
          "title": "Pathogenesis of DJ-1/PARK7-Mediated Parkinson's Disease.",
          "journal": "Cells",
          "year": "2024",
          "citationCount": 49,
          "influentialCitationCount": 2,
          "isReview": true,
          "studyType": "review",
          "studyDesign": null,
          "sampleSize": null,
          "sampleSizeText": null,
          "openAccessUrl": "https://www.mdpi.com/2073-4409/13/4/296/pdf?version=1707203655",
          "evidencePolarity": "support",
          "evidenceSignals": {
            "supportHits": 2,
            "contradictHits": 0
          },
          "contradictionTags": [],
          "contradictionSummary": null,
          "contradictionSeverity": null,
          "journalTier": "tier1",
          "trialPhase": null,
          "isRetracted": false,
          "evidenceItems": [],
          "evidenceCount": 0,
          "evidenceScore": 4.82,
          "evidenceScoreComponents": {
            "citations": 2.04,
            "influential": 0.43,
            "sampleSize": 0,
            "evidenceItems": 0,
            "evidenceSignals": 0.4,
            "recency": 0.35,
            "studyType": 0.6,
            "studyDesign": 0,
            "polarity": 0.4,
            "journalTier": 0.6,
            "trialPhase": 0,
            "retraction": 0
          }
        },
        {
          "pmid": "38368937",
          "title": "Retromer-dependent lysosomal stress in Parkinson's disease.",
          "journal": "Philosophical transactions of the Royal Society of London. Series B, Biological sciences",
          "year": "2024",
          "citationCount": 5,
          "influentialCitationCount": 0,
          "isReview": true,
          "studyType": "review",
          "studyDesign": null,
          "sampleSize": null,
          "sampleSizeText": null,
          "openAccessUrl": "https://royalsocietypublishing.org/doi/pdf/10.1098/rstb.2022.0376",
          "evidencePolarity": "neutral",
          "evidenceSignals": {
            "supportHits": 0,
            "contradictHits": 0
          },
          "contradictionTags": [],
          "contradictionSummary": null,
          "contradictionSeverity": null,
          "journalTier": "tier1",
          "trialPhase": null,
          "isRetracted": false,
          "evidenceItems": [],
          "evidenceCount": 0,
          "evidenceScore": 2.48,
          "evidenceScoreComponents": {
            "citations": 0.93,
            "influential": 0,
            "sampleSize": 0,
            "evidenceItems": 0,
            "evidenceSignals": 0,
            "recency": 0.35,
            "studyType": 0.6,
            "studyDesign": 0,
            "polarity": 0,
            "journalTier": 0.6,
            "trialPhase": 0,
            "retraction": 0
          }
        },
        {
          "pmid": "39983584",
          "title": "LRRK2, lysosome damage, and Parkinson's disease.",
          "journal": "Current opinion in cell biology",
          "year": "2025",
          "citationCount": 12,
          "influentialCitationCount": 0,
          "isReview": true,
          "studyType": "review",
          "studyDesign": null,
          "sampleSize": null,
          "sampleSizeText": null,
          "openAccessUrl": null,
          "evidencePolarity": "neutral",
          "evidenceSignals": {
            "supportHits": 0,
            "contradictHits": 0
          },
          "contradictionTags": [],
          "contradictionSummary": null,
          "contradictionSeverity": null,
          "journalTier": "tier1",
          "trialPhase": null,
          "isRetracted": false,
          "evidenceItems": [],
          "evidenceCount": 0,
          "evidenceScore": 2.89,
          "evidenceScoreComponents": {
            "citations": 1.34,
            "influential": 0,
            "sampleSize": 0,
            "evidenceItems": 0,
            "evidenceSignals": 0,
            "recency": 0.35,
            "studyType": 0.6,
            "studyDesign": 0,
            "polarity": 0,
            "journalTier": 0.6,
            "trialPhase": 0,
            "retraction": 0
          }
        },
        {
          "pmid": "38377788",
          "title": "Gut microbiome, short-chain fatty acids, alpha-synuclein, neuroinflammation, and ROS/RNS: Relevance to Parkinson's disease and therapeutic implications.",
          "journal": "Redox biology",
          "year": "2024",
          "citationCount": 84,
          "influentialCitationCount": 1,
          "isReview": true,
          "studyType": "review",
          "studyDesign": null,
          "sampleSize": null,
          "sampleSizeText": null,
          "openAccessUrl": "https://doi.org/10.1016/j.redox.2024.103092",
          "evidencePolarity": "neutral",
          "evidenceSignals": {
            "supportHits": 0,
            "contradictHits": 0
          },
          "contradictionTags": [],
          "contradictionSummary": null,
          "contradictionSeverity": null,
          "journalTier": "tier3",
          "trialPhase": null,
          "isRetracted": false,
          "evidenceItems": [],
          "evidenceCount": 0,
          "evidenceScore": 3.69,
          "evidenceScoreComponents": {
            "citations": 2.32,
            "influential": 0.27,
            "sampleSize": 0,
            "evidenceItems": 0,
            "evidenceSignals": 0,
            "recency": 0.35,
            "studyType": 0.6,
            "studyDesign": 0,
            "polarity": 0,
            "journalTier": 0.15,
            "trialPhase": 0,
            "retraction": 0
          }
        },
        {
          "pmid": "38438297",
          "title": "GBA1-and LRRK2-directed Treatments: The Way Forward.",
          "journal": "Parkinsonism & related disorders",
          "year": "2024",
          "citationCount": 7,
          "influentialCitationCount": 0,
          "isReview": true,
          "studyType": "review",
          "studyDesign": null,
          "sampleSize": null,
          "sampleSizeText": null,
          "openAccessUrl": null,
          "evidencePolarity": "neutral",
          "evidenceSignals": {
            "supportHits": 0,
            "contradictHits": 0
          },
          "contradictionTags": [],
          "contradictionSummary": null,
          "contradictionSeverity": null,
          "journalTier": "tier3",
          "trialPhase": null,
          "isRetracted": false,
          "evidenceItems": [],
          "evidenceCount": 0,
          "evidenceScore": 2.18,
          "evidenceScoreComponents": {
            "citations": 1.08,
            "influential": 0,
            "sampleSize": 0,
            "evidenceItems": 0,
            "evidenceSignals": 0,
            "recency": 0.35,
            "studyType": 0.6,
            "studyDesign": 0,
            "polarity": 0,
            "journalTier": 0.15,
            "trialPhase": 0,
            "retraction": 0
          }
        },
        {
          "pmid": "38614108",
          "title": "RAB32 Ser71Arg in autosomal dominant Parkinson's disease: linkage, association, and functional analyses.",
          "journal": "The Lancet. Neurology",
          "year": "2024",
          "citationCount": 67,
          "influentialCitationCount": 0,
          "isReview": false,
          "studyType": "mixed",
          "studyDesign": "case-control",
          "sampleSize": 6043,
          "sampleSizeText": "6043 individuals",
          "openAccessUrl": "http://www.thelancet.com/article/S1474442224001212/pdf",
          "evidencePolarity": "neutral",
          "evidenceSignals": {
            "supportHits": 0,
            "contradictHits": 0
          },
          "contradictionTags": [],
          "contradictionSummary": null,
          "contradictionSeverity": null,
          "journalTier": "tier1",
          "trialPhase": null,
          "isRetracted": false,
          "evidenceItems": [
            {
              "pmid": "38614108",
              "label": "p=0",
              "context": "affected individuals; non-parametric linkage Z score=1·95; p=0·03). 2604 unrelated individuals with Parkinson's disease an"
            },
            {
              "pmid": "38614108",
              "label": "n=16",
              "context": "disease presented at age 54·6 years (SD 12·75, range 31-81, n=16), and two-thirds had a family history of parkinsonism. RAB3"
            }
          ],
          "evidenceCount": 2,
          "evidenceScore": 7.84,
          "evidenceScoreComponents": {
            "citations": 2.2,
            "influential": 0,
            "sampleSize": 2.84,
            "evidenceItems": 0.7,
            "evidenceSignals": 0,
            "recency": 0.35,
            "studyType": 0.8,
            "studyDesign": 0.35,
            "polarity": 0,
            "journalTier": 0.6,
            "trialPhase": 0,
            "retraction": 0
          }
        },
        {
          "pmid": "39199337",
          "title": "Novel Therapeutic Horizons:  Targeting in Parkinson's Disease.",
          "journal": "Biomolecules",
          "year": "2024",
          "citationCount": 7,
          "influentialCitationCount": 0,
          "isReview": true,
          "studyType": "review",
          "studyDesign": null,
          "sampleSize": null,
          "sampleSizeText": null,
          "openAccessUrl": "https://www.mdpi.com/2218-273X/14/8/949/pdf?version=1722933019",
          "evidencePolarity": "neutral",
          "evidenceSignals": {
            "supportHits": 0,
            "contradictHits": 0
          },
          "contradictionTags": [],
          "contradictionSummary": null,
          "contradictionSeverity": null,
          "journalTier": "tier3",
          "trialPhase": null,
          "isRetracted": false,
          "evidenceItems": [],
          "evidenceCount": 0,
          "evidenceScore": 2.18,
          "evidenceScoreComponents": {
            "citations": 1.08,
            "influential": 0,
            "sampleSize": 0,
            "evidenceItems": 0,
            "evidenceSignals": 0,
            "recency": 0.35,
            "studyType": 0.6,
            "studyDesign": 0,
            "polarity": 0,
            "journalTier": 0.15,
            "trialPhase": 0,
            "retraction": 0
          }
        },
        {
          "pmid": "39074992",
          "title": "Parkinson's disease variant detection and disclosure: PD GENEration, a North American study.",
          "journal": "Brain : a journal of neurology",
          "year": "2024",
          "citationCount": 58,
          "influentialCitationCount": 2,
          "isReview": false,
          "studyType": "mixed",
          "studyDesign": null,
          "sampleSize": 510,
          "sampleSizeText": "510 participants",
          "openAccessUrl": "https://academic.oup.com/brain/article-pdf/147/8/2668/58712400/awae142.pdf",
          "evidencePolarity": "neutral",
          "evidenceSignals": {
            "supportHits": 0,
            "contradictHits": 0
          },
          "contradictionTags": [],
          "contradictionSummary": null,
          "contradictionSeverity": null,
          "journalTier": "tier3",
          "trialPhase": null,
          "isRetracted": false,
          "evidenceItems": [
            {
              "pmid": "39074992",
              "label": "510 participants",
              "context": "Between September 2019 and June 2023, the study enrolled 10 510 participants across >85 centres, with 8301 having received results. Part"
            }
          ],
          "evidenceCount": 1,
          "evidenceScore": 6.24,
          "evidenceScoreComponents": {
            "citations": 2.13,
            "influential": 0.43,
            "sampleSize": 2.03,
            "evidenceItems": 0.35,
            "evidenceSignals": 0,
            "recency": 0.35,
            "studyType": 0.8,
            "studyDesign": 0,
            "polarity": 0,
            "journalTier": 0.15,
            "trialPhase": 0,
            "retraction": 0
          }
        }
      ],
      "insightLinks": {
        "pathways": [
          {
            "id": "pathway-0",
            "label": "Parkinson disease - Homo sapiens (human)",
            "citations": [
              "PMID:39153957",
              "PMID:38621236"
            ],
            "pmids": [
              "39153957",
              "38621236"
            ],
            "supportingPmids": [
              "39153957"
            ],
            "contradictingPmids": [],
            "mixedPmids": [],
            "evidenceSnippets": [],
            "evidenceStatus": "unverified",
            "quantitativeData": "Not reported in abstracts",
            "quantEvidence": [],
            "trustRationale": "Supported by 1/2 papers; top support PMID:39153957 (TIER3, review, score 3.53).",
            "evidenceBadge": {
              "label": "Preliminary evidence",
              "level": "preliminary",
              "score": 0.52,
              "supportCount": 1,
              "contradictCount": 0,
              "detail": "Support 1 • Contradict 0 • Top journal TIER3 • Preclinical/unknown"
            },
            "provenance": {
              "supportingPmids": [
                "39153957"
              ],
              "contradictingPmids": [],
              "mixedPmids": [],
              "trustRationale": "Supported by 1/2 papers; top support PMID:39153957 (TIER3, review, score 3.53).",
              "evidenceBadge": {
                "label": "Preliminary evidence",
                "level": "preliminary",
                "score": 0.52,
                "supportCount": 1,
                "contradictCount": 0,
                "detail": "Support 1 • Contradict 0 • Top journal TIER3 • Preclinical/unknown"
              }
            }
          },
          {
            "id": "pathway-1",
            "label": "Pathways of neurodegeneration - multiple diseases - Homo sapiens (human)",
            "citations": [
              "PMID:38391909",
              "PMID:38368937"
            ],
            "pmids": [
              "38391909",
              "38368937"
            ],
            "supportingPmids": [
              "38391909"
            ],
            "contradictingPmids": [],
            "mixedPmids": [],
            "evidenceSnippets": [],
            "evidenceStatus": "unverified",
            "quantitativeData": "Not reported in abstracts",
            "quantEvidence": [],
            "trustRationale": "Supported by 1/2 papers; top support PMID:38391909 (TIER1, review, score 4.82).",
            "evidenceBadge": {
              "label": "Moderate confidence",
              "level": "moderate",
              "score": 0.75,
              "supportCount": 1,
              "contradictCount": 0,
              "detail": "Support 1 • Contradict 0 • Top journal TIER1 • Preclinical/unknown"
            },
            "provenance": {
              "supportingPmids": [
                "38391909"
              ],
              "contradictingPmids": [],
              "mixedPmids": [],
              "trustRationale": "Supported by 1/2 papers; top support PMID:38391909 (TIER1, review, score 4.82).",
              "evidenceBadge": {
                "label": "Moderate confidence",
                "level": "moderate",
                "score": 0.75,
                "supportCount": 1,
                "contradictCount": 0,
                "detail": "Support 1 • Contradict 0 • Top journal TIER1 • Preclinical/unknown"
              }
            }
          }
        ],
        "strategies": [
          {
            "id": "strategy-0",
            "label": "LRRK2 kinase inhibition",
            "citations": [
              "PMID:38438297",
              "PMID:39199337"
            ],
            "pmids": [
              "38438297",
              "39199337"
            ],
            "supportingPmids": [],
            "contradictingPmids": [],
            "mixedPmids": [],
            "evidenceSnippets": [],
            "evidenceStatus": "unverified",
            "quantitativeData": "Not reported in abstracts",
            "quantEvidence": [],
            "trustRationale": "No direct support in 2 cited papers.",
            "evidenceBadge": {
              "label": "Evidence sparse",
              "level": "sparse",
              "score": 0,
              "supportCount": 0,
              "contradictCount": 0,
              "detail": "No supporting papers linked"
            },
            "provenance": {
              "supportingPmids": [],
              "contradictingPmids": [],
              "mixedPmids": [],
              "trustRationale": "No direct support in 2 cited papers.",
              "evidenceBadge": {
                "label": "Evidence sparse",
                "level": "sparse",
                "score": 0,
                "supportCount": 0,
                "contradictCount": 0,
                "detail": "No supporting papers linked"
              }
            }
          },
          {
            "id": "strategy-1",
            "label": "Alpha-synuclein targeting therapies",
            "citations": [
              "PMID:39199337",
              "PMID:39983584"
            ],
            "pmids": [
              "39199337",
              "39983584"
            ],
            "supportingPmids": [],
            "contradictingPmids": [],
            "mixedPmids": [],
            "evidenceSnippets": [],
            "evidenceStatus": "unverified",
            "quantitativeData": "Not reported in abstracts",
            "quantEvidence": [],
            "trustRationale": "No direct support in 2 cited papers.",
            "evidenceBadge": {
              "label": "Evidence sparse",
              "level": "sparse",
              "score": 0,
              "supportCount": 0,
              "contradictCount": 0,
              "detail": "No supporting papers linked"
            },
            "provenance": {
              "supportingPmids": [],
              "contradictingPmids": [],
              "mixedPmids": [],
              "trustRationale": "No direct support in 2 cited papers.",
              "evidenceBadge": {
                "label": "Evidence sparse",
                "level": "sparse",
                "score": 0,
                "supportCount": 0,
                "contradictCount": 0,
                "detail": "No supporting papers linked"
              }
            }
          },
          {
            "id": "hypothesis-0",
            "label": "Novel hypothesis: The interplay between LRRK2 and DJ-1 in regulating mitochondrial dynamics may provide a novel therapeutic target.",
            "citations": [
              "PMID:38391909",
              "PMID:38377788"
            ],
            "pmids": [
              "38391909",
              "38377788"
            ],
            "supportingPmids": [
              "38391909"
            ],
            "contradictingPmids": [],
            "mixedPmids": [],
            "evidenceSnippets": [],
            "evidenceStatus": "unverified",
            "quantEvidence": [],
            "trustRationale": "Supported by 1/2 papers; top support PMID:38391909 (TIER1, review, score 4.82).",
            "evidenceBadge": {
              "label": "Moderate confidence",
              "level": "moderate",
              "score": 0.75,
              "supportCount": 1,
              "contradictCount": 0,
              "detail": "Support 1 • Contradict 0 • Top journal TIER1 • Preclinical/unknown"
            },
            "provenance": {
              "supportingPmids": [
                "38391909"
              ],
              "contradictingPmids": [],
              "mixedPmids": [],
              "trustRationale": "Supported by 1/2 papers; top support PMID:38391909 (TIER1, review, score 4.82).",
              "evidenceBadge": {
                "label": "Moderate confidence",
                "level": "moderate",
                "score": 0.75,
                "supportCount": 1,
                "contradictCount": 0,
                "detail": "Support 1 • Contradict 0 • Top journal TIER1 • Preclinical/unknown"
              }
            }
          }
        ],
        "topics": [
          {
            "id": "topic-0",
            "label": "Genetic contributions to Parkinson's disease",
            "citations": [
              "PMID:39153957",
              "PMID:38614108"
            ],
            "pmids": [
              "39153957",
              "38614108"
            ],
            "supportingPmids": [
              "39153957"
            ],
            "contradictingPmids": [],
            "mixedPmids": [],
            "evidenceSnippets": [
              "[object Object]",
              "[object Object]"
            ],
            "evidenceStatus": "grounded",
            "quantEvidence": [
              {
                "pmid": "38614108",
                "label": "p=0",
                "context": "affected individuals; non-parametric linkage Z score=1·95; p=0·03). 2604 unrelated individuals with Parkinson's disease an"
              },
              {
                "pmid": "38614108",
                "label": "n=16",
                "context": "disease presented at age 54·6 years (SD 12·75, range 31-81, n=16), and two-thirds had a family history of parkinsonism. RAB3"
              }
            ],
            "trustRationale": "Supported by 1/2 papers; top support PMID:39153957 (TIER3, review, score 3.53).",
            "evidenceBadge": {
              "label": "Preliminary evidence",
              "level": "preliminary",
              "score": 0.52,
              "supportCount": 1,
              "contradictCount": 0,
              "detail": "Support 1 • Contradict 0 • Top journal TIER3 • Preclinical/unknown"
            },
            "provenance": {
              "supportingPmids": [
                "39153957"
              ],
              "contradictingPmids": [],
              "mixedPmids": [],
              "trustRationale": "Supported by 1/2 papers; top support PMID:39153957 (TIER3, review, score 3.53).",
              "evidenceBadge": {
                "label": "Preliminary evidence",
                "level": "preliminary",
                "score": 0.52,
                "supportCount": 1,
                "contradictCount": 0,
                "detail": "Support 1 • Contradict 0 • Top journal TIER3 • Preclinical/unknown"
              }
            }
          }
        ]
      },
      "hypothesisLinks": [
        {
          "id": "a163bc9d58579f84",
          "type": "drug_repurposing",
          "statement": "PALBOCICLIB may be repurposed to treat Parkinson's disease",
          "confidence": 0.8984615384615384,
          "evidenceStrength": 1,
          "pmids": [],
          "supportingPmids": [],
          "contradictingPmids": [],
          "mixedPmids": [],
          "evidenceSummary": [
            {
              "type": "target_overlap",
              "source": null,
              "weight": 0.6,
              "gene": "LRRK2"
            },
            {
              "type": "target_overlap",
              "source": null,
              "weight": 0.6,
              "gene": "LRRK2"
            },
            {
              "type": "target_overlap",
              "source": null,
              "weight": 0.6,
              "gene": "LRRK2"
            },
            {
              "type": "target_overlap",
              "source": null,
              "weight": 0.6,
              "gene": "LRRK2"
            }
          ],
          "quantEvidence": [],
          "trustRationale": "No linked papers for this claim.",
          "evidenceBadge": {
            "label": "Evidence sparse",
            "level": "sparse",
            "score": 0,
            "supportCount": 0,
            "contradictCount": 0,
            "detail": "No supporting papers linked"
          },
          "provenance": {
            "supportingPmids": [],
            "contradictingPmids": [],
            "mixedPmids": [],
            "trustRationale": "No linked papers for this claim.",
            "evidenceBadge": {
              "label": "Evidence sparse",
              "level": "sparse",
              "score": 0,
              "supportCount": 0,
              "contradictCount": 0,
              "detail": "No supporting papers linked"
            }
          }
        },
        {
          "id": "fb64a298cfc9fe7f",
          "type": "drug_repurposing",
          "statement": "VANDETANIB may be repurposed to treat Parkinson's disease",
          "confidence": 0.8984615384615384,
          "evidenceStrength": 1,
          "pmids": [],
          "supportingPmids": [],
          "contradictingPmids": [],
          "mixedPmids": [],
          "evidenceSummary": [
            {
              "type": "target_overlap",
              "source": null,
              "weight": 0.6,
              "gene": "LRRK2"
            },
            {
              "type": "target_overlap",
              "source": null,
              "weight": 0.6,
              "gene": "LRRK2"
            },
            {
              "type": "target_overlap",
              "source": null,
              "weight": 0.6,
              "gene": "LRRK2"
            },
            {
              "type": "target_overlap",
              "source": null,
              "weight": 0.6,
              "gene": "LRRK2"
            }
          ],
          "quantEvidence": [],
          "trustRationale": "No linked papers for this claim.",
          "evidenceBadge": {
            "label": "Evidence sparse",
            "level": "sparse",
            "score": 0,
            "supportCount": 0,
            "contradictCount": 0,
            "detail": "No supporting papers linked"
          },
          "provenance": {
            "supportingPmids": [],
            "contradictingPmids": [],
            "mixedPmids": [],
            "trustRationale": "No linked papers for this claim.",
            "evidenceBadge": {
              "label": "Evidence sparse",
              "level": "sparse",
              "score": 0,
              "supportCount": 0,
              "contradictCount": 0,
              "detail": "No supporting papers linked"
            }
          }
        },
        {
          "id": "95ff7e4ee462b6f8",
          "type": "drug_repurposing",
          "statement": "ENTRECTINIB may be repurposed to treat Parkinson's disease",
          "confidence": 0.8984615384615384,
          "evidenceStrength": 1,
          "pmids": [],
          "supportingPmids": [],
          "contradictingPmids": [],
          "mixedPmids": [],
          "evidenceSummary": [
            {
              "type": "target_overlap",
              "source": null,
              "weight": 0.6,
              "gene": "LRRK2"
            },
            {
              "type": "target_overlap",
              "source": null,
              "weight": 0.6,
              "gene": "LRRK2"
            },
            {
              "type": "target_overlap",
              "source": null,
              "weight": 0.6,
              "gene": "LRRK2"
            },
            {
              "type": "target_overlap",
              "source": null,
              "weight": 0.6,
              "gene": "LRRK2"
            }
          ],
          "quantEvidence": [],
          "trustRationale": "No linked papers for this claim.",
          "evidenceBadge": {
            "label": "Evidence sparse",
            "level": "sparse",
            "score": 0,
            "supportCount": 0,
            "contradictCount": 0,
            "detail": "No supporting papers linked"
          },
          "provenance": {
            "supportingPmids": [],
            "contradictingPmids": [],
            "mixedPmids": [],
            "trustRationale": "No linked papers for this claim.",
            "evidenceBadge": {
              "label": "Evidence sparse",
              "level": "sparse",
              "score": 0,
              "supportCount": 0,
              "contradictCount": 0,
              "detail": "No supporting papers linked"
            }
          }
        },
        {
          "id": "9bd6b34e06de890a",
          "type": "drug_repurposing",
          "statement": "ADAVOSERTIB may be repurposed to treat Parkinson's disease",
          "confidence": 0.8984615384615384,
          "evidenceStrength": 1,
          "pmids": [],
          "supportingPmids": [],
          "contradictingPmids": [],
          "mixedPmids": [],
          "evidenceSummary": [
            {
              "type": "target_overlap",
              "source": null,
              "weight": 0.6,
              "gene": "LRRK2"
            },
            {
              "type": "target_overlap",
              "source": null,
              "weight": 0.6,
              "gene": "LRRK2"
            },
            {
              "type": "target_overlap",
              "source": null,
              "weight": 0.6,
              "gene": "LRRK2"
            },
            {
              "type": "target_overlap",
              "source": null,
              "weight": 0.6,
              "gene": "LRRK2"
            }
          ],
          "quantEvidence": [],
          "trustRationale": "No linked papers for this claim.",
          "evidenceBadge": {
            "label": "Evidence sparse",
            "level": "sparse",
            "score": 0,
            "supportCount": 0,
            "contradictCount": 0,
            "detail": "No supporting papers linked"
          },
          "provenance": {
            "supportingPmids": [],
            "contradictingPmids": [],
            "mixedPmids": [],
            "trustRationale": "No linked papers for this claim.",
            "evidenceBadge": {
              "label": "Evidence sparse",
              "level": "sparse",
              "score": 0,
              "supportCount": 0,
              "contradictCount": 0,
              "detail": "No supporting papers linked"
            }
          }
        },
        {
          "id": "e7ea6b6bc7e4fbe2",
          "type": "drug_repurposing",
          "statement": "AST-487 may be repurposed to treat Parkinson's disease",
          "confidence": 0.8984615384615384,
          "evidenceStrength": 1,
          "pmids": [],
          "supportingPmids": [],
          "contradictingPmids": [],
          "mixedPmids": [],
          "evidenceSummary": [
            {
              "type": "target_overlap",
              "source": null,
              "weight": 0.6,
              "gene": "LRRK2"
            },
            {
              "type": "target_overlap",
              "source": null,
              "weight": 0.6,
              "gene": "LRRK2"
            },
            {
              "type": "target_overlap",
              "source": null,
              "weight": 0.6,
              "gene": "LRRK2"
            },
            {
              "type": "target_overlap",
              "source": null,
              "weight": 0.6,
              "gene": "LRRK2"
            }
          ],
          "quantEvidence": [],
          "trustRationale": "No linked papers for this claim.",
          "evidenceBadge": {
            "label": "Evidence sparse",
            "level": "sparse",
            "score": 0,
            "supportCount": 0,
            "contradictCount": 0,
            "detail": "No supporting papers linked"
          },
          "provenance": {
            "supportingPmids": [],
            "contradictingPmids": [],
            "mixedPmids": [],
            "trustRationale": "No linked papers for this claim.",
            "evidenceBadge": {
              "label": "Evidence sparse",
              "level": "sparse",
              "score": 0,
              "supportCount": 0,
              "contradictCount": 0,
              "detail": "No supporting papers linked"
            }
          }
        }
      ]
    },
    "evidenceScorecard": {
      "papers": {
        "support": 8,
        "contradict": 0,
        "mixed": 0,
        "neutral": 21
      },
      "insights": {
        "total": 6,
        "withSupport": 4,
        "withContradictions": 0,
        "withMixed": 0,
        "withoutCitations": 0
      },
      "hypotheses": {
        "total": 5,
        "withSupport": 0,
        "withContradictions": 0,
        "withMixed": 0
      },
      "citationWarnings": 0,
      "consensus": {
        "supportWeight": 8.35,
        "contradictWeight": 0,
        "mixedWeight": 0,
        "totalWeight": 8.35,
        "consensusRatio": 1,
        "contentionRatio": 0,
        "netConsensus": 1,
        "consensusLabel": "Strong",
        "contentionLabel": "Low"
      }
    },
    "qualityMetrics": {
      "score": 63,
      "groundedRatio": 0.2,
      "groundedCount": 1,
      "insightCount": 5,
      "pathways": 2,
      "strategies": 2,
      "topics": 1,
      "hypotheses": 5,
      "papersUsed": 9,
      "evidenceItems": 3,
      "evidencePapers": 2,
      "sourcesAvailable": 14,
      "sourcesTotal": 16
    },
    "learningMemory": {
      "source": "knowledge-graph-cache",
      "pathways": [
        {
          "pathway": "undefined",
          "geneOverlap": [
            "SNCA",
            "LRRK2",
            "PARK7"
          ],
          "confidence": "cached"
        }
      ],
      "message": "Instant results from previous analyses! (No API calls needed)"
    },
    "audience": "clinician",
    "audienceLabel": "Clinician-focused view",
    "generatedAtIso": "2026-01-16T13:35:29.502Z",
    "analysisTime": "55742ms",
    "modelConfig": {
      "aiModelUsed": "GPT-4o-mini",
      "modelTimeoutMs": 90000,
      "providers": {
        "openai": true,
        "deepseek": true,
        "gemini": false,
        "anthropic": true
      },
      "modelIds": {
        "openai": "gpt-4o-mini",
        "deepseek": "deepseek-chat",
        "gemini": "gemini-2.0-flash-exp",
        "anthropic": "claude-3-5-sonnet-latest"
      },
      "includeDrugs": true
    },
    "dataSource": {
      "genes": "Ensembl + ClinVar + UniProt + Gene Ontology",
      "pathways": "KEGG + Reactome v95",
      "literature": "PubMed + Semantic Scholar",
      "interactions": "STRING",
      "clinical": "Open Targets + GWAS Catalog",
      "drugs": "DGIdb + PubChem + ChEMBL",
      "ai": "GPT-4o-mini",
      "hypothesisEngine": "GaiaLab AI (Graph Neural Networks + Probabilistic Reasoning)"
    },
    "dataAvailability": {
      "literature": {
        "pubmed": true,
        "semanticScholar": true
      },
      "pathways": {
        "kegg": true,
        "reactome": true
      },
      "interactions": {
        "string": true,
        "biogrid": false
      },
      "clinical": {
        "openTargets": true,
        "disgenet": false,
        "gwasCatalog": true
      },
      "drugs": {
        "chembl": true,
        "drugbank": false,
        "drugbankFallback": false,
        "dgidb": true,
        "pubchem": true
      }
    },
    "databaseStats": {
      "totalDatabases": 16,
      "availableDatabases": [
        "Ensembl",
        "ClinVar",
        "UniProt",
        "Gene Ontology",
        "KEGG",
        "Reactome v95",
        "PubMed",
        "Semantic Scholar",
        "STRING",
        "Open Targets",
        "GWAS Catalog",
        "DGIdb",
        "PubChem",
        "ChEMBL"
      ],
      "availableCount": 14,
      "bioactiveCompounds": "2.4M+",
      "databases": [
        "UniProt",
        "KEGG",
        "Reactome",
        "PubMed",
        "STRING",
        "Open Targets",
        "BioGRID",
        "Gene Ontology",
        "Ensembl",
        "GWAS Catalog",
        "DisGeNET",
        "ClinVar",
        "ChEMBL",
        "PubChem",
        "DrugBank",
        "Semantic Scholar"
      ]
    },
    "snapshot": null,
    "disclaimer": "AI-generated insights for research purposes. Requires expert validation. Not medical advice.",
    "cacheStats": {
      "cached": false,
      "timestamp": 1768570585261,
      "tier": "fresh",
      "hitRate": "0.0"
    }
  },
  "modelConfig": {
    "aiModelUsed": "GPT-4o-mini",
    "modelTimeoutMs": 90000,
    "providers": {
      "openai": true,
      "deepseek": true,
      "gemini": false,
      "anthropic": true
    },
    "modelIds": {
      "openai": "gpt-4o-mini",
      "deepseek": "deepseek-chat",
      "gemini": "gemini-2.0-flash-exp",
      "anthropic": "claude-3-5-sonnet-latest"
    },
    "includeDrugs": true
  },
  "versions": {
    "app": "0.1.0",
    "node": "v22.18.0"
  },
  "signature": "6d740084eda1"
}